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ABSTRACT 
The research presented in this thesis serves to provide a tool to autonomously 
screen for cardiovascular disease in the rural areas of Africa. Vital information 
thus obtained from patients can be communicated to advanced medical centres by 
Telemedicine. Cardiovascular disease is then detected in its initial stages, which is 
essential to its effective treatment. The system developed in this study uses re-
corded heart sounds and electrocardiogram signals to distinguish between normal 
and abnormal heart conditions. This system improves on standard diagnostic tools 
in that it does not require cumbersome and expensive imaging equipment or a 
highly trained operator. 
Heart sound- and electrocardiogram signals from 62 volunteers were recorded 
with the prototype Precordialcardiogram device as part of a clinical study to aid in 
the development of the autonomous auscultation software and to screen patients 
for cardiovascular disease. These volunteers consisted of 28 patients of Tygerberg 
Hospital with cardiovascular disease and, for control purposes, 34 persons with 
normal heart conditions. 
The autonomous auscultation system developed during this study, interprets 
data obtained with the Precordialcardiogram device to autonomously acquire a 
normal or abnormal diagnosis. The system employs wavelet soft thresholding to 
denoise the recorded signals, followed by the segmentation of heart sound by 
identifying peaks in the electrocardiogram. Novel frequency spectral information 
was extracted as features from the heart sounds, by means of ensemble empirical 
mode decomposition and auto regressive modelling. These features proved to be 
particularly significant and played a major role in the screening capability of the 
system. New time domain based features were identified, established on the spe-
cific characteristics of the various cardiovascular diseases encountered during the 
study. These features were extracted via the energy ratios between different parts 
of ventricular systole and diastole of each recorded cardiac cycle. 
The respective features were classified to characterise typical heart diseases as 
well as healthy hearts with an ensemble artificial neural network. Herein the deci-
sions of all the members were combined to obtain a final diagnosis. The perform-
ance of the autonomous auscultation system used in concert with the Precordial-
cardiogram device prototype, as determined through the leave-one-out cross-
validation method, had a sensitivity rating of 82% and a specificity rating of 88%. 
These results demonstrate the potential benefit of the Precordialcardiogram device 
and the developed autonomous auscultation software in a Telemedicine environ-
ment. 
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SINOPSIS 
Hierdie tesis beskryf die navorsing van 'n outonome toetsing en sifting stelsel 
vir kardiovaskulêre siektes in landelike dele van Afrika, vanwaar mediese inlig-
ting per telefoon versend kan word. Die apparaat maak vroeë opsporing van kar-
diovaskulêre siektes moontlik, wat essensieel is vir effektiewe behandeling daar-
van en ook die koste-effek van hierdie siektes verminder. In die huidige ontwik-
kelde stelsel word normale sowel as abnormale hart-toestande getipeer met op-
names van hartklanke sowel as elektrokardiogram-seine. Voordele wat hierdie 
stelsel bo standaard diagnostiese metodes het, sluit die hanteerbare formaat van 
die hele apparaat sowel as die nie-noodsaaklikheid van duur beeldskeppende ap-
paraat, of hoogs opgeleide personeel. 
Hartklank- en elektrokardiogramseine van 62 vrywilligers is met die prototipe 
"Precordialcardiogram" apparaat opgeneem om by te dra tot die ontwikkeling van 
die rekenaar sagteware vir die outonome auscultatsie stelsel en om die pasiënt-
siftingsvermoë daarvan te toets. Die vrywilligers het 28 pasiënte van Tygerberg 
hospitaal met abnormale harttoestande ingesluit, sowel as ‘n kontrolegroep van 34 
persone met normale harttoestande. Die outonome auskultasie-stelsel wat tot stand 
gekom het deur hierdie ondersoek maak gebruik van “wavelet” sagte drempeling 
om geraas uit die opgeneemde seine te verwyder. Daarna word die hartklanke ge-
segmenteer deur die pieke van die elektrokardiogram te identifiseer. 
Deur middel van "ensemble empirical mode decomposition" en outo-
regressiewe modellering, is nuwe inligting aangaande die frekwensie spektra van 
hartklanke, aanwysend van spesifieke harttoestande, verkry. Die beduidendheid 
van hierdie eienskappe is bewys en het 'n belangrike rol in die siftingsvermoë van 
die stelsel gespeel. Hierbenewens is nuwe tyd-gebaseerde eienskappe van die 
onderskeie kardiovaskulêre siektes wat tydens die ondersoek bestudeer is, geïden-
tifiseer. Hierdie eienskappe is geëien deur die energie-verhoudings tussen verskil-
lende dele van die ventrikulêre sistolie en diastolie van elke opgeneemde hartsik-
lus te ontleed. 
'n "Ensemble artificial neural network" is gebruik om die geïdentifiseerde eien-
skappe van hartsiektes sowel as normale harttoestande, te klassifiseer. Hierin is 
besluite van al die lede van die netwerk gekombineer, ten einde ‘n finale  diag-
nose te maak. Die klassifiseerder se geldigheid is kruis-bevestig deur middel van 
die laat-een-uit kruisbevestigings-metode.   
Deur middel van die kruis-bevestigingsmetode is die bedryfsvermoëns van die 
outonome auskultasie-stelsel, toegerus met die "Precordialcardiogram" apparaat, 
repektiewelik op 82% vir sensitiwiteit en 88% vir spesifisiteit vasgestel. Hierdie 
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resultate demonstreer die benuttingspotensiaal van die apparaat in 'n Telemedi-
syne omgewing. 
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1. INTRODUCTION 
Cardiac auscultation, the technique of listening to heart sounds with a stetho-
scope, has been the primary means of diagnosing cardiovascular disease (CVD) 
since the early 19th century. One of the first applications of modern auscultation 
has been in the aerospace industry where, since the 1980’s, electronic stetho-
scopes were embedded in astronauts’ suits to allow monitoring of their cardiac 
activity (Nicogossian et al., 2001). 
The sounds produced by the human heart have been studied extensively and 
forms the basis of many clinicians’ preliminary diagnosis. But, cardiac ausculta-
tion is a difficult skill to master and is limited by the clinician’s ability to discern 
the components which constitute the heart sounds. In South Africa, let alone the 
rest of Africa, there are only a few specialists trained in the skill of auscultation. 
Auscultation also fails to provide a qualitative and quantitative measure with 
which to formulate a diagnosis (Visagie, 2007). Recently, auscultation is being 
complimented by phonocardiography with the aim of assisting physicians in their 
diagnosis. Phonocardiography is the recording of heart sounds with electronic 
stethoscopes and displaying their waveforms. However, heart sounds exhibit 
complex nonlinear and non-stationary characteristics which are not clearly dis-
cernible simply by viewing phonocardiogram images.  
With the advent of advanced imaging technologies such as echocardiography, 
computed tomography and magnetic resonance imaging, clinicians may have fur-
ther neglected the vital skill of auscultation. However sophisticated these imaging 
techniques may be, they are usually performed at a high cost and are not always 
available to patients, especially in rural areas or underserved communities.  
The research presented in this thesis therefore aims to assist clinicians in the 
early detection of CVD. Through the development of a software system with the 
capability to automatically analyse and classify heart sounds either as normal or 
abnormal, this primary aim was accomplished. The developed system employed 
advanced signal processing and pattern recognition techniques, such as the em-
pirical mode decomposition and ensemble neural networks, to autonomously 
screen patients for CVD. The system was tested in a clinical study where data was 
recorded with the prototype Precordialcardiogram (PCG) device, developed by 
GeoAxon Holdings, South Africa. Data was obtained from patients who suffered 
from CVD as well as from healthy participants, to serve as control for the experi-
ment. All the participants were examined by a trained cardiologist and an echo-
cardiograph, which is the commonly used gold standard for diagnosis of CVD, to 
verify their diagnosis and to validate the autonomous auscultation software system 
developed during this study. 
Advantages related to the implementation of this system in a product such as 
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the prototype PCG device, will include major savings with regards to valuable 
specialist time through the avoidance of unnecessary referrals and the ability to 
automatically detect CVD in its early stages. This is paramount for its effective 
treatment to avoid serious long-term complications and permanent damage to the 
heart. Through the development of the autonomous auscultation software, this re-
search will have far reaching consequences with regard to making modern health-
care more accessible to all patients. 
1.1 Motivation and Background 
Between 1997 and 2004, approximately 200 people died per day in South Af-
rica because of some form of cardiovascular disease, with more than half of those 
occurring below the age of 65 years (Steyn, 2007). Premature deaths caused by 
CVD in people of working age (35-64 years) are expected to increase by 40% be-
tween 2000 and 2030 (Steyn, 2007). In 1991, the cost of CVD to the South Afri-
can economy fell between R4.135 and R5.035 billion, which did not include the 
costs of rehabilitation and follow-up. This expenditure reflects 2%-3% of the 
gross domestic product or roughly 25% of all healthcare expenditure in South Af-
rica (Pestana et al., 1996). According to Steyn (2007), early diagnosis and treat-
ment of CVD is essential to lower the burden on the economy and improve patient 
survivability.  
By comparison, the South African National survey for HIV, 2008, showed that 
18% of all South African adults were living with HIV and that in 2006, 41% of all 
deaths in South Africa were as a result of AIDS. The cost of HIV and AIDS on 
the South African economy is estimated to be 17% of its gross domestic product 
by 2010 (Ministry of Health, 2009). 
Many cardiovascular diseases cause murmurs and aberrations in heart sounds 
even before they produce other noticeable symptoms, such as physiological 
changes or changes in the electrocardiogram (Huiying et al., 1997). Detection of 
these sounds can thus aid in the early diagnosis of these types of cardiovascular 
diseases and result in more effective treatment by preventing permanent damage 
to the heart (Visagie, 2007). 
Patients identified with cardiovascular disease are generally referred to a cardi-
ologist. However, rural areas in South Africa currently suffer from the absence of 
such specialists. The medical personnel currently working in these areas, who are 
responsible for screening populations for cardiovascular disease, might not have 
the proper training or skills required for diagnosing such diseases through auscul-
tation(Lubbe, 2009).  
Telemedicine can be described as the use telecommunication technology to de-
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liver healthcare services to sites that are physically distant from the host service 
provider. The Medical Research Counsel of South Africa has announced that the 
South African government is, “committed to providing basic healthcare to all 
South African citizens”, and to achieve this goal the government has, “identified 
Telemedicine as a strategic tool for facilitating the delivery of equitable healthcare 
services”.  
The use of the PCG device as a screening tool to assist in the auscultation of 
patients will prove useful to healthcare workers in rural communities, by improv-
ing the early detection of cardiovascular abnormalities and preventing inappropri-
ate referrals. The PCG device, with screening capabilities, has the potential to 
bring professional medical services closer to the rural population by sending re-
corded patient data via Telemedicine to a specialist for review (Lubbe, 2009).  
1.2 Research Objectives 
The objective of this research project is to develop software capable of detect-
ing CVD from heart sounds recorded with electronic stethoscopes. In order to 
achieve this objective the following must be accomplished: 
1. Record heart sounds and electrocardiogram (ECG) data from patients 
with CVD as well as from healthy participants. 
2. Research and implement suitable signal processing algorithms for the de-
tection of anomalies in the recorded heart sounds which would indicate 
the presence of CVD. 
3. Develop an automated classification scheme that can successfully parti-
tion the healthy participants from those with CVD. 
4. Cross-validate the implemented classification scheme in a clinical study 
to determine its capability to screen future patients. 
5. Investigate the strengths, weaknesses, feasibility and the acceptance of 
the recording hardware by patients and clinicians in a hospital environ-
ment. 
1.3 Thesis Outline 
Chapter 2 starts with a background to the cardiac cycle, heart sounds and the 
electrical activity in the heart. Current literature and advances in the field of 
autonomous auscultation is also reviewed. 
Stellenbosch University http://scholar.sun.ac.za
4 
Chapter 3 discuss the clinical study conducted with the prototype Precordial-
cardiogram (PCG) device. The previous generation hardware prototype, the Aus-
cultation Jacket, and the data recorded with it are also briefly discussed. Thereaf-
ter, the data pre-processing steps are described.  
In Chapter 4, the autonomous auscultation system implementation is discussed. 
The chapter includes the denoising and segmentation of heart sounds, as well as 
feature extraction and classification. 
The results from cross-validation are presented in Chapter 5 and the conclu-
sions and recommendations of the study are presented in Chapter 6. 
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2. LITERATURE REVIEW 
This chapter gives an introduction to the human cardiovascular system, the 
functionality of the human heart and the sounds it produces. Background to the 
electrical system and measurement of the electrical activity within the human 
heart is also presented. A review of various signal processing techniques that has 
been used to analyse heart sounds is given and a comparison of different classifi-
cation methods with respect to screening for CVD is made. The chapter concludes 
with a summary of the methods employed in this study and a comparison to pre-
vious studies is drawn. 
2.1 The Cardiovascular System and the Cardiac Cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Cardiovascular circulatory system (Martini & 
Bartholomew, 2003). 
Stellenbosch University http://scholar.sun.ac.za
6 
The blood in the human body flows through a network of blood vessels (Figure 
1) which connects the heart and peripheral tissue. The blood vessels can be cate-
gorised in two circuits. The pulmonary circuit carries deoxygenated blood from 
the heart to the lungs and return oxygenated blood from the lungs back to the 
heart. The systemic circuit carries oxygenated blood to the rest of the body and 
returns the deoxygenated blood back to the heart. The blood is propelled through 
these circuits in sequence, by the heart (Martini & Bartholomew, 2003).  
The right atrium delivers deoxygenated blood to the heart from the systemic 
circuit (Figure 2). The right ventricle then pumps the blood to the pulmonary cir-
cuit during ventricular contraction. The left atrium collects oxygenated blood 
from the pulmonary circuit which it feeds to the left ventricle. The left ventricle 
then pumps the blood through the systemic circuit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Frontal-section of the human heart (Martini & 
Bartholomew, 2003). 
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Four heart valves separate the atria and the systemic- and pulmonary circuits 
from the ventricles. The valves separating the atria and ventricles are the tricuspid 
and mitral (bicuspid) valves (Figure 2). The tricuspid valve consists of three 
cusps, while the mitral valve of only two. These cusps are connected to the inner 
cardiac muscle with tendons called the cordae tendineae. The purpose of the mi-
tral and tricuspid valves is to prohibit the backflow of blood from the ventricles 
into the atria during ventricular contraction, but to allow blood flow when the ven-
tricles are relaxed. Separating the ventricles and the pulmonary and systemic cir-
cuits are the pulmonary and aortic valves. These valves are also called semilunar 
valves, due to their shape. Their purpose is to prevent the backflow of blood into 
the ventricles from the pulmonary and aortic arteries when the ventricles relax af-
ter contraction (Martini & Bartholomew, 2003). 
The cardiac cycle starts with atrial systole, when the atria contract to com-
pletely fill the ventricles with blood. Thereafter, atrial diastole and ventricular sys-
tole initiates simultaneously. During ventricular systole, the ventricles contract, 
forcing blood into the aortic and pulmonary arteries. When the ventricles relax 
after contraction, the ventricles and atria are mutually in diastole which lasts until 
atrial systole starts again, marking the start of a new cycle. The contractions of the 
atria are generally much weaker than that of the ventricles and not of as much 
concern. Therefore, in the remainder of this document, the terms systole and dias-
tole are used to refer to ventricular systole and ventricular diastole, unless other-
wise stated. 
2.2 Heart Sounds and Auscultation 
The sounds produced by the beating of the human heart are chiefly caused by 
the opening and closing of heart valves, as well as by the turbulence of the blood 
flowing through them. These sounds are named by a numbering convention which 
initiates at the start of systole. The two predominant sounds produced by a healthy 
heart can be described as “lubb-dubb” sounds and are called S1 and S2 respec-
tively. Figure 4a) shows a heart sound recording (phonocardiogram) of a healthy 
volunteer, recorded with the PCG device, depicting S1 and S2. S1, heard at the 
start of systole, is largely caused by the closing of the mitral and tricuspid valves. 
S2 occurs at the onset of diastole and is mainly caused by the closure of the pul-
monary and aortic valves (Martini & Bartholomew, 2003). 
S3 is usually a low pitched sound and is prevalent in athletes with a slow 
heartbeat. In older patients, S3 usually indicates ventricular malfunction. S4 is 
caused by the contraction of the atria and the resulting movement of blood from 
the atria to the ventricles. A prominent S4 heart sound is usually caused by an 
enlarged or overgrown atrium pumping blood through a healthy tricuspid or mitral 
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valve (OSU Medical Centre, 2008). Extra sounds, indicating malfunctioning or 
diseased heart valves, include ejection sounds, clicks, snaps, rubs and rumbles.  
Ejection sounds are usually caused by blood being pumped through a stenosed 
pulmonary or aortic valve. A stenosed valve is one which does not open properly 
and cause resistance to blood flow. In the case of mitral stenosis a diastolic rum-
ble sound is usually heard after an opening snap. Clicks are extra sounds resulting 
from an elongation or rupture of the chordea tendons of either the tricuspid or mi-
tral valves. The clicking sound is produced by the leaflets of such a valve moving 
into an atrium as the ventricles contract. Snaps are high-pitched sounds caused by 
the forward movement of a stenosed mitral or tricuspid valve as the ventricles re-
lax during diastole. Pericardial rubbing sounds can be heard when the sack sur-
rounding the heart becomes inflamed. The inflammation is usually the result of a 
viral infection and causes the wall of the heart muscle to rub against the pericar-
dium.  
Auscultation of the heart (the technique of listening to heart sounds), is usually 
performed at four specific positions on the thorax. These positions are situated 
where the sounds produced at each of the four heart valves are best heard and is 
also referred to by their respective heart valve names: tricuspid, mitral, pulmonic 
and aortic. Figure 3 shows the relative locations of the heart valves and their aus-
cultation positions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Heart valve and auscultation positions (Human, n.d.). 
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2.3 The Electrocardiogram 
Contractions of the heart are controlled by a network of specialized muscle 
cells termed the conduction system of the heart. The conduction system, shown in 
Figure 5, initiates and distributes electrical impulses through the cardiac tissue. 
These electrical events, which cause the heart to contract, are detectable by meas-
uring voltage potentials on the skin of a person’s chest. A recorded time series 
depicting these voltages is called an electrocardiogram (ECG). Analysis of an 
ECG is useful in detecting cardiac arrhythmias and in the timing of cardiac cycles 
(Martini & Bartholomew, 2003). 
 
 
A typical ECG trace is shown in Figure 4b). The different waveforms num-
bered P to T represent the sequence of depolarization and repolarisation of the 
atria and ventricles. The P-wave represents the depolarisation of the atria. An ac-
tion potential starts at the sinoatrial (SA) node (Figure 5) and propagates through 
the left and right atria causing them to contract simultaneously. The flat line be-
tween the P-wave and Q is the time the action potential travels through the atrio-
ventricular (AV) node and the bundle of HIS. 
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Figure 4: Synchronised recording of a healthy volunteer: a) 
Heart sound. b) ECG.  
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The QRS-complex represents ventricular depolarisation. It contains the highest 
peak in the ECG trace since the ventricular muscle is much larger than that of the 
atria. Contraction of the ventricles starts shortly after the R-wave. The flat line 
segment between S and T is the time the ventricles remain depolarized and the T-
wave indicates ventricular repolarisation. Atrial repolarisation is not apparent in 
the ECG trace since it occurs at the same time (and is masked by) the QRS-
complex (Martini & Bartholomew, 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4 Previous Research 
A summary of previous research in the fields constituting autonomous auscul-
tation is presented in this section. These include the denoising of heart sounds, 
segmentation of heart sounds, signal processing methods applicable to the study 
of heart sounds and classification schemes based on heart sound features. Finally, 
a comparison between previous research and this study is drawn. 
Figure 5: Electrical system of the heart (OSU Medical Centre, 
2008). 
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2.4.1 Denoising 
Signal contamination is a phenomenon present in most physical measurements. 
Its effect is to corrupt the data being measured by introducing false and unwanted 
information (noise) to the data. The presence of noise in any measurement is fre-
quently related to two causes: 1) Environmental effects unrelated to the sampling 
procedure, and 2) constraints owed to the physical nature of the sampling hard-
ware or the recording procedure. The effects of noise can often be reduced 
through software filters and denoising algorithms such as those discussed in the 
following paragraphs.  
Adaptive filters have been widely used in applications where the statistical 
characteristics of the signals to be denoised are either unknown or time variant 
(non-stationary), such as in the case of heart sounds. Two classes of algorithms 
are frequently used to calculate the adaptive filter coefficients, 1) the least-means-
square algorithm and 2) the recursive least-squares algorithm (Proakis & 
Manolakis, 2007). Multireference adaptive noise cancelling has been successfully 
used to improve the signal to noise ratio (SNR) of electroencephalograms (EEG) 
(James et al., 1997). Mittra et al. (2007) compared various denoising techniques 
for foetal phonocardiograms and concluded that adaptive filtering using the recur-
sive least-squares algorithm is an appropriate methodology for these signals 
(Mittra et al., 2007).  
Wavelet threshold denoising has been used extensively to denoise heart sound 
recordings. The heart sounds are decomposed into wavelet coefficients of which 
some are removed using a thresholding strategy. The remaining coefficients are 
recomposed to yield the denoised heart sound. The parameters for wavelet denois-
ing are the chosen wavelet family, the level at which to perform the decomposi-
tion and the method used for calculating the threshold. The performance of differ-
ent types of wavelets for the purpose of denoising heart sounds has been evaluated 
by Messer et al. (2001). Their research concluded that wavelets from the De-
bouche families decomposed at the 5th level produced the best denoising results 
when applied to heart sounds.  
2.4.2 Segmentation 
The purpose of heart sound segmentation is to separate all the cardiac cycles in 
a recording so that each can be analysed individually. Three methods are currently 
employed to segment heart sounds. The first is to manually mark the start of each 
cycle by listening to the sounds. This is typically done by a cardiologist trained in 
cardiac auscultation.  
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The second involves applying sophisticated algorithms to the heart sounds. 
These algorithms are designed to automatically recognise recurring sounds in the 
recording which it uses as the basis for segmentation. The third method is to re-
cord an ECG or use a heartbeat monitor synchronous to the heart sound recording. 
The QRS peaks in the ECG are detected using a peak detection algorithm and is 
used to mark the start of each cardiac cycle. 
The start of systole can be identified effectively using an ECG synchronised to 
the heart sound recording, but the start of diastole in the cardiac cycle then still 
needs to be determined. Malarvilli et al. (2003) computed the instantaneous fre-
quencies of ECG recordings to segment heart sounds and identify S1 and S2. 
They found the method to be effective in segmenting their data which consisted of 
210 recorded abnormal cardiac cycles (Malarvili et al., 2003). Rangayyan (2002) 
proposed a method for segmenting heart sounds by applying a first derivative op-
erator and moving average (MA) filter to the ECG (Rangayyan, 2002). 
Automatic segmentation of heart sounds without an ECG has previously been 
implemented in autonomous auscultation systems through the application of com-
plex signal processing techniques. Torry and Mood (1995) implemented auto re-
gressive modelling to estimate the power spectral densities and energies in certain 
frequency bands to segment heart sounds. In their study they applied their method 
to the segmentation of 30 patients’ heart sounds and found that the segmentation 
agreed largely with that performed by a cardiologist, who listened to the heart 
sounds (Torry & Mood, 1995). Liang et al. (1997) based segmentation on the 
normalized Shannon energy of the phonocardiogram. Their method correctly 
segmented 93% of 37 patient recordings (Liang et al., 1997). Gupta et al. (2005) 
proposed a novel method for segmenting heart sounds by using homomorphic fil-
tering and k-means clustering and reported good segmentation performance 
(Gupta et al., 2005). Gamero & Watrous (2003) segmented heart sounds by mod-
elling systole and diastole using hidden Markov models as probabilistic finite 
state-machines. They evaluated their segmentation method with the phonocardio-
grams of 80 patients and obtained detection sensitivity for S1 and S2 of 93% and 
a detection positive predictive value of 97% (Gamero & Watrous, 2003). 
2.4.3 Signal Processing 
Many physical signals produced by natural phenomena such as the human 
heartbeat are best characterized statistically as random processes. Heart sounds 
exhibit extremely nonlinear and non-stationary characteristics and can only be ob-
served for a finite duration (Visagie, 2007). The effect of this is that the length of 
the recording generally determines the time variation of the signal statistics. These 
characteristics, exhibited by heart sounds, make them a challenge to analyse in an 
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automated way and signal processing techniques that preserves time and fre-
quency information needs to be employed (Reed et al., 2004). Some of the promi-
nent methods, generally regarded to be suitable for analysing signals of this type, 
include the short time Fourier transform (STFT), wavelet analysis and, the re-
cently proposed empirical mode decomposition (EMD) (Ari & Saha, 2008).  
The STFT applies traditional Fourier spectral analysis to a finite, short time 
window of the data. The window is then slid across the data record to obtain a 
time-frequency distribution. This method is easily implemented and makes use of 
the well-defined and popular Fourier transform. However, a disadvantage of this 
method is that it assumes the data to be piece-wise stationary. This has been 
shown to rarely be the case with heart sounds revealing abnormal cardiac condi-
tions (Reed et al., 2004). Sengur & Turkoglu (2008) extracted features based on 
the STFT from heart sounds and have shown them to be capable of accurately 
separating normal and certain abnormal heart conditions through classification 
with their artificial neural network (Sengur & Turkoglu, 2008). 
Wavelet analysis is a non-parametric spectral analysis method which allows for 
an adjustable windowing length, as opposed to the STFT. It has proved to be very 
useful in analysing data which exhibit gradual frequency changes, but it suffers 
from leakage due to the limited length of the wavelet function. Debbal and Bere-
ski (2004) were able to identify the aortic and pulmonary components in the sec-
ond heart sound along with their frequency range and localization using wavelet 
analysis (Debbal & Bereksi, 2004). Ning et al. (2009) used wavelets and auto re-
gressive modelling to analyse heart sounds and showed that it provided a quantita-
tive means with which to delineate systolic murmurs (Ning et al., 2009).  
EMD is a method that has been designed for analysing complex data such as 
those typically representing natural phenomena. Originally the method was used 
for studying ocean currents, but because of its advantages its application has 
spread to other fields, including the analysis of heart sounds. The most applicable 
advantage of the method is that it is able to uniquely decompose a non-linear, 
non-stationary time series into a sum of oscillatory components. The decomposi-
tion method is adaptive and based solely on the signal itself, contrary to methods 
employing Fourier transforms whose basis functions are linear combinations of 
fixed sinusoids (Huang et al., 1998). Charleston et al. (2006) has shown EMD to 
be capable of separating native heart sound components by, first validating the 
method on simulated heart sounds, and then testing it on real heart sound re-
cordings (Charleston et al., 2006). Echeverria et al. (2001) has shown EMD to be 
able to provide useful features from heart sounds for the study of heart rate vari-
ability (Echeverria et al., 2001). The EMD method has also been implemented for 
the purpose of autonomous auscultation. Ari and Saha (2008) compared features 
extracted from heart sounds using EMD and wavelet analysis by classifying the 
features with a grow-and-learn network and an artificial neural network. They re-
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ported that the EMD-based features generally resulted in better classification per-
formance between normal and abnormal heart sounds, than the corresponding 
wavelet based features. In their study, they reported an overall classification accu-
racy of 95% with the EMD features and artificial neural networks (Ari & Saha, 
2008).  
2.4.4 Classification 
Artificial neural networks (ANN) have been widely implemented for the pur-
pose of classifying heart sounds. They are able to model complex nonlinear sys-
tems by using parametric forms for its basis functions, in which the parameters are 
adapted during training. The most successful type of ANN, in the context of pat-
tern recognition, is the feed-forward neural network, also known as the multilayer 
perceptron (Bishop, 2006). Other notable methods that have successfully been 
implemented to classify heart sound features are support vector machines and 
hidden Markov models. A comparison of classification results and methods that 
has been reported in studies involved in the field of autonomous auscultation is 
presented in the following paragraphs.  
Gupta et al. (2005) implemented Debouchies-2 wavelet detail coefficients, de-
composed at the 2nd level, as features in their multilayer perceptron (MLP) neural 
network. The wavelet coefficients amounted to 32 features which they used to 
classify between normal and abnormal heart sounds. They reported a correct clas-
sification performance of 90% based on their heart sound data, which consisted of 
230 abnormal and 110 normal cardiac cycles (Gupta et al., 2005). Sinha et al. 
(2007) performed wavelet decomposition of phonocardiograms with a Coifman 
4th order wavelet kernel. They used the coefficients as features in an ANN classi-
fication system to detect signs of mitral regurgitation in the recordings and ob-
tained a correct classification performance of 95% in their clinical study (Sinha et 
al., 2007). Turkoglu et al. (2002) extracted features from Doppler heart sounds 
using wavelet transforms and the STFT. They implemented the features in an 
ANN for classification and obtained correct classification rates of 94% for normal 
participants and 96% for abnormal patients (Turkoglu et al., 2002). Leung et al. 
(2000) used the trimmed-mean-spectrogram time-frequency analysis method to 
extract features from recorded phonocardiograms. They implemented the features 
in an ANN and tested the system in a clinical trial consisting of 18 normal partici-
pants and 37 abnormal patients. Their system was able to achieve a sensitivity of 
97% and a specificity of 94% (Leung et al., 2000). Andrisevic et al. (2005) devel-
oped an autonomous auscultation system with an ANN classifier. They used prin-
cipal component analysis (PCA) and block processing to prepare features for the 
network. They obtained a sensitivity of 64.7% and specificity of 70.5% by screen-
ing for CVD with their system (Andrisevic et al., 2005). 
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Ensemble artificial neural networks have been shown by previous research to 
give more accurate results under certain conditions compared to unitary networks. 
The objective of an ensemble of neural networks is to combine the individual out-
puts of each ensemble member to obtain better generalisation. Sharkey (1996) 
first published an overview on the research of combining artificial neural net-
works and the fundamental challenges involved with such an approach. Some of 
the challenges include combining the outputs of ensemble members and methods 
used for creating candidate ensemble members (Sharkey, 1996). Dietterich (2000) 
showed in a study of machine learning methods how ensembles of classifiers can 
have remarkable advantages over single classifiers (Dietterich, 2000). Zhou et al. 
(2001) used an ensemble artificial neural network to successfully identify lung 
cancer cells in images. Gilbert & Tan (2003) compared ensemble classification 
methods to single classifiers and found that the ensemble often produced better 
results than single classifiers in their study of detecting cancer using gene expres-
sion data. Liu et al. (2004) implemented ensemble artificial neural networks to 
also classify gene expressions and found that it considerably improved accuracy 
and robustness compared to their previous, single ANN. Bhatikar et al. (2004) de-
veloped a screening system for CVD in paediatrics based on a decision-of-experts 
ensemble ANN classification scheme. They have shown, through a clinical study, 
that their system obtained a sensitivity and specificity of 88% and 83% respec-
tively.  
Other schemes employed in the classification of heart sounds include hidden 
Markov models (HMM), k-nearest neighbours, support vector machines (SVM) 
and linear discriminant models (Visagie, 2007). Sengur & Turkoglu (2008) devel-
oped a fuzzy k-NN heart sound classification system to detect heart valve disease 
and obtained a sensitivity and specificity of 95.9% and 96% respectively from 
testing 215 sample recordings. Chauhan et al. (2008) introduced a Mel-frequency 
ceptral coefficient to extract features from heart sounds. They used HMM to clas-
sify these features and obtained 90% classification accuracy for detecting diastolic 
murmurs. 
2.5 Comparison of the Present Study with Previous Re-
search 
The study presented in this thesis follows directly from previous work done by 
Visagie (2007). However, the aim of this study was to use the new prototype Pre-
cordialcardiogram (PCG) device (Figure 6) to record data in a clinical environ-
ment and to use it as a platform for the development of the auscultation software 
to autonomously screen patients for CVD.  
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Synchronised stethoscope- and ECG signals from multiple sensors in the PCG 
device was employed in this study, similar to that of Visagie (2007), to record pa-
tient data. In contrast to many other methods reviewed, the PCG device procides 
the ability to observe a unique heart sound event at various auscultation positions, 
along with its characteristic ECG traces. Operation of the PCG device, unlike the 
auscultation jacket (Figure 9) used by Visagie (2007), is designed to be straight-
forward so that a trained nurse could quickly and effortlessly screen patients for 
CVD (Koekemoer & Scheffer, 2008). The PCG device and associated hardware is 
also designed to be low-cost to enable its swift deployment at many medical cen-
tres without the need for large capital investment. Table 1 gives a cost comparison 
between a standard ECG and echocardiograph (currently employed at medical 
centres) and an estimated cost of a commercial PCG device with embedded 
screening capabilities. 
To develop and validate the performance of the autonomous auscultation sys-
tem of this study, 60 participants’ heart sounds and ECG signals were recorded at 
Tygerberg Hospital with the PCG device. Subsequently, the physical abilities of 
the device and its feasibility in a hospital environment were assessed and the per-
formance of the entire system was determined. The performance of the system 
was calculated in terms of the sensitivity, specificity, accuracy, predictive values 
and likelihood ratios so that it can be accurately compared to previous studies. 
These measures are also used to describe the usefulness of the autonomous aus-
cultation system as a diagnostic and screening tool. Additionally, the system is 
designed to give a novel confidence percentage on every diagnosis to indicate 
how conclusive a particular screening result is. 
The software developed in this study denoises all the recorded heart sounds 
with wavelet soft threshold denoising. This method is similar to that used by Vis-
agie (2007) as well as other studies on the denoising of heart sounds, as discussed 
in Section 2.4.1. In this study, the method was found to accurately denoise the 
heart sounds without removing significant oscillations.  
Segmentation of the heart sounds was performed with the assistance of the in-
ternal ECG in the PCG device. The segmentation algorithm takes into account the 
time history of successive identified peaks to assist in the elimination of falsely 
identified QRS-peaks in the ECG. The method proved extremely robust and per-
formed successful segmentations even on very noisy ECG traces, such as illus-
trated in Figure 17 and Figure 22.  
In the present study, novel use of the ensemble empirical mode decomposition 
was made to study heart sounds and analyse them in an automated way. With its 
ability to identify significant oscillation modes, the developed software can 
uniquely use auto regressive modelling to extract features for use as input to the 
ensemble ANN classification scheme. Ensemble neural network decisions are 
then combined to obtain a diagnosis as well as a confidence percentage on that 
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diagnosis. This ability gives the autonomous auscultation system developed in this 
study a clear advantage and makes it a much more valuable tool for providing de-
cision support to clinicians when compared to many of the previously proposed 
systems. 
 
 
 Echocardiograph ECG PCG device 
Capital Expense R500,000 R20,000 R40,000 
Operator  Sonographer Nurse Nurse 
Salary expense R160,000 R130,000 R130,000 
 
2.6 Chapter Summary 
This chapter presented an introduction to the cardiovascular system and the 
features of heart sounds. It gave a review on various signal processing methods 
previously used to study and classify heart sounds for the purpose of screening for 
CVD. Finally, the main differences and similarities between the present study and 
previous studies were discussed. 
 
Table 1: Cost comparison of cardiac diagnostic resources 
(Koekemoer, 2008). 
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3. HARDWARE AND DATA AQUISITION 
This chapter describes the Auscultation Jacket and Precordialcardiogram 
(PCG) prototype devices that have been used to record heart sounds and ECG 
data. The clinical study performed at Tygerberg Hospital to record data with the 
PCG device is described and preparation of the recorded data, before it is submit-
ted to the auscultation software, is explained. The chapter concludes with the de-
velopment of a single-lead ECG, which samples data through a universal serial 
bus (USB) mini-soundcard, to extend the capability of the PCG device.  
3.1 Precordialcardiogram device 
The PCG prototype is a handheld device produced for this study by GeoAxon 
Holdings Pty. Ltd. It is designed to fit the average adult’s chest to record ECG and 
heart sound signals (Koekemoer & Scheffer, 2008). It has a commercial, 12-lead 
ECG (IQTec, Cape Town, South Africa) and four electronic stethoscopes embed-
ded inside the plastic housing. The device connects to (and is powered by) a per-
sonal computer (PC) via a USB hub and two USB extension cables. The PC con-
trols the recording of signals and stores the recordings on its hard drive for analy-
sis by the autonomous auscultation software.  
 
 
Figure 6 shows the PCG device placed over the chest such that a recording can 
be made. The lateral part of the device can hinge separately to the main embodi-
Figure 6: Prototype Precordialcardiogram device, top view 
(photos: JSF Botha).  
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ment, allowing the device to snugly fit most adults’ chest circumferences 
(Koekemoer & Scheffer, 2008). The ECG electrodes can be seen in Figure 7 
whilst the stethoscopes and diaphragms, housed beneath green silicone jelly, can-
not be seen directly. Figure 8 shows the inside of the PCG housing. The pulmonic 
and aortic electronic stethoscopes can be seen on the left of the figure. The IQtec 
ECG and Soundcard-ECG is mounted vertically in the centre of the device and the 
USB soundcard and USB hub is on the right.  
The stethoscopes sample at a resolution of 16-bits and a frequency of 8 kHz, 
whilst the ECG samples electrical potentials on the skin at 500 Hz. The ECG and 
stethoscope signals are synchronised at the start of each recording by tapping the 
device to create intentional artefacts. These artefacts then serve as reference to 
synchronise the signals manually after recordings were made. The location of the 
stethoscopes in the PCG housing is designed so that it coincides with the regular 
auscultation positions shown in Figure 3 (Koekemoer & Scheffer, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Recordings of 60 volunteers were made at Tygerberg Hospital as part of the 
clinical study of this research project. The volunteers comprised of 30 healthy par-
ticipants for experimental control and 30 patients with some or other cardiovascu-
lar disease that is detectable through auscultation. Unfortunately, two of the pa-
tients with abnormal heart conditions and five of the normal participants’ re-
ECG Electrodes
Aortic
Pulmonic
Tricuspid
Mitral
Figure 7: Prototype Precordialcardiogram device showing 
stethoscope positions and ECG electrodes (photo: JSF Botha). 
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USB Soundcard
IQTec ECG
Soundcard ECG
Stethoscope
cordings could not be synchronised because of poor ECG quality. Subsequently, 
their data could not be used to evaluate the classification system. The causes un-
derlying the poor ECG recording quality are discussed further in Section 6.2. To 
make up for the loss of data, nine more volunteers with normal heart conditions 
were recorded. The total amount of usable data collected with the PCG device 
therefore amounted to 28 abnormal (with heart disease) and 34 normal (no heart 
disease) participants with 3 to 4 minutes of ECG and heart sounds each.  
 
 
 
 
 
 
 
 
 
 
 
 
3.2 Auscultation Jacket 
The Auscultation Jacket used in the research of Visagie (2007), is designed to 
record heart sounds, lung sounds, ECG and impedance cardiogram (ICG) signals 
simultaneously from several sensors. The sensing elements consist of electronic 
stethoscopes for the sound recordings and electrodes for the ECG and ICG.  
The body of the Auscultation Jacket is made from flexible neoprene foam and 
is designed to fit the patient such that the position of the electronic stethoscopes 
coincides with the normal auscultation locations (Koekemoer & Scheffer, 2008). 
Figure 9 shows the Auscultation Jacket fitted to a mannequin to illustrate how it 
would fit a patient. The fitment of the neckpiece housing the ICG electrodes is 
also shown. 
Figure 8: PCG device showing electronic stethoscopes, IQTec 
ECG, soundcard ECG, USB soundcard and USB hub (photo: 
JSF Botha). 
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The location of the stethoscopes inside the neoprene is shown in Figure 10. The 
stethoscopes sample data at a resolution of 16-bits and a frequency of 2 kHz 
whilst the ECG and ICG sample at 500 Hz (Koekemoer & Scheffer, 2008).  
 
 
 
Participant recordings performed with the Auscultation Jacket in 2005 
(Visagie, 2007) were used additional to the data collected during the present 
study. The recordings, made with the Auscultation Jacket, were of 21 patients 
who presented with cardiovascular disease and 31 healthy volunteers for experi-
mental control. Due to the shape of the Auscultation Jacket, these recordings were 
performed exclusively on male volunteers (Visagie, 2007). 
Figure 9: Auscultation Jacket fitted over mannequin 
(Koekemoer & Scheffer, 2008) 
Figure 10: Auscultation Jacket showing stethoscopes and ECG 
electrodes (Koekemoer & Scheffer, 2008) 
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3.3 Clinical study at Tygerberg Hospital using the PCG 
device 
For the clinical study, data from 62 participants was successfully recorded us-
ing the PCG prototype device at the TREAD research facility at Tygerberg Hospi-
tal. The procedure for performing recordings, outlined in the participant consent 
form in Appendix B, and summarised in Appendix C, was approved by the Com-
mittee for Human Research of the University of Stellenbosch (Nr. N07/02/026).  
The purpose of using the PCG device to performing the recordings on patients 
was on the one hand to increase the size of the local heart sound and ECG data-
base which, to date, only consisted of recordings made with the Auscultation 
Jacket. The recordings were also used to determine how accurately the imple-
mented classification scheme was able to detect the presence of CVD in cross-
validation tests and to evaluate the feasibility of such a system in a hospital envi-
ronment. 
The participants that were successfully recorded comprised of 37 male and 25 
female volunteers and ranged from 13 years to 79 years of age. Twenty eight of 
the participants presented with CVD detectable through auscultation and 34 were 
normal, healthy volunteers for experimental control. Most of the abnormal pa-
tients presented severe cases of mitral regurgitation (MR), mitral stenosis (MS), 
aortic regurgitation (AR), aortic stenosis (AS), or ventricular septal defect (VSD). 
These abnormal conditions are discussed in more detail in Section 4.4.1 as part of 
the pathology-based analysis. Tables 2 and 3 show a summary of all the partici-
pants’ information and the number of occurrences of each of the abnormal condi-
tions. Most the abnormal patients presented combinations of these conditions with 
only a few conditions appearing on their own.  
To verify the diagnosis of each participant’s heart condition, each underwent 
an examination by a trained cardiologist using an echocardiograph. The echocar-
diograph is regarded as the gold standard in cardiac diagnostics and the results 
were used during the present study as a benchmark with which to compare the re-
sults of the developed autonomous auscultation system. A standard 12-lead ECG 
was used by Dr Lubbe (Lubbe, 2009), to record an electrocardiogram for each 
participant. All the participants had to sign the written consent form presented in 
Appendix B and the procedure for performing the recordings as listed in Appen-
dix C, was followed for everyone. The details describing all the participants’ in-
formation, the results of the echocardiograph and the conclusions of the cardiolo-
gist’s examinations are listed in Table A4. 
Three recording runs, also referred to as instances, were performed for each 
participant. The duration of each instance is approximately one minute or 70~90 
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cardiac cycles. During each instance the participant was instructed to inhale 
deeply and then to exhale, but not to inhale again for as long as possible. In a few 
cases the recording duration was shorter since cardiovascular disease caused a se-
vere lack of stamina in some of the patients. To ensure that the length of the re-
cordings was not taken into account by the classification system, the extracted 
features were averaged over all the recorded cycles of each participant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4 Data Preparation 
Data preparation is necessary to save all the recordings into a standard format 
to enable the automated auscultation system to analyse and classify the data. This 
step has been deemed impractical to form part of the automated process since an 
open electronic medical record (EMR) standard does not yet exist for recording 
and saving synchronised ECG and heart sound signals.  
The first task was to resample the ECG to the same sampling frequency as the 
 Maximum Minimum Average 
Age 79 years 13 years 39 years 
Weight 128 kg 45 kg 73 kg 
Height 194 cm 152 cm 168 cm 
Abnormal Condition Number of occurrences 
Mitral regurgitation 11 
Mitral stenosis 6 
Aortic regurgitation 8 
Aortic stenosis 10 
Ventricular septal defect  2 
Pulmonary stenosis 1 
Table 2: Summary of participants in clinical study. 
Table 3: Occurrences of abnormal conditions in participants. 
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heart sound, 8 kHz in this case. One of the ECG channels, which recorded clearly, 
was chosen for segmentation and converted and saved in the same file format as 
the heart sounds. Intentional artefacts in the signals, created at the start of each 
recording, were then used to synchronize the ECG and heart sounds manually. 
Finally, the unusable portions in the recordings are removed and the result is 
saved in a 5-channel pulse-code modulated waveform audio format file. The first 
four channels in the file are the signals from the four electronic stethoscopes at the 
mitral, tricuspid, pulmonary and aortic auscultation positions (Figure 3) and the 
fifth is the ECG signal.  
The recordings of each participant was organised by a naming convention. For 
example, the file name DATA03_1_2.wav refered to participant identification 
number 3, instance 1, part 2. The recording instance is a single recording run dur-
ing which the participant was instructed to exhale and hold his or her breath. 
Some of the instances are broken down into parts (shorter recording strips) be-
cause they contained segments with excessive noise. The noise was primarily 
caused by people talking at a nearby examination or instruction is being given to 
the participant. These pieces of unusable recording are removed and the instance 
was consequently split into several parts. 
3.5 Soundcard-ECG 
To overcome the difficulties involved in synchronizing the commercial, 12-
lead, IQTec ECG and stethoscopes built into the PCG device, an analogue ECG 
pre-amplifier circuit board, referred to as the Soundcard-ECG (Figure 11), was 
designed and built for the PCG device for use in future trials. The circuit diagram 
and printed circuit board layout of the Soundcard-ECG is presented in Appendix 
E. The Soundcard-ECG uses the analogue to digital converter of a small USB 
soundcard’s microphone input to capture a single-lead ECG trace.  
A raw recording of the Soundcard-ECG is shown in Figure 12b). The ECG is 
automatically synchronised with the heart sound, Figure 12a), by the recording 
software. The recording illustrates that it is feasible and practical to record a good 
quality ECG for heart sound segmentation purposes by using a low-cost USB 
sound card. 
The USB soundcard and ECG is compact enough to fit inside the PCG device 
housing alongside the IQTec ECG, as shown in Figure 8. The major advantage of 
this device is that the stethoscopes and Soundcard-ECG are automatically syn-
chronized by the audio recording software since the Soundcard-ECG now use the 
same winsound-device drivers as the electronic stethoscopes. The device is also 
cheap (less than R300), compact, and easy to assemble. The device is powered 
exclusively by the computer’s USB port through which the data is also sampled.  
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Figure 11: Soundcard-ECG (photo: JSF Botha). 
Figure 12: a) PCG heart sound recording. b) Raw Soundcard-
ECG recording, automatically synchronised with sound in 
Figure 12 a). 
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3.6 Chapter Summary 
The clinical study conducted with the PCG device at Tygerberg Hospital to 
screen patients for CVD is discussed. The components and functionality of the 
PCG device is outlined and the preparation of data that has been recorded with it, 
is described. In addition, the design and manufacture of an analogue ECG 
(Soundcard-ECG) which automatically synchronize with the heart sound re-
cording, is explained.  
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4. METHODOLOGY 
This chapter discusses the software implementation of the autonomous auscul-
tation system. The system components chronologically send data to each other, as 
shown in Figure 13, to ultimately provide a normal (healthy heart condition) or 
abnormal (CVD present) diagnosis. The implementation was done in the Matlab 
(Mathworks Inc., Massachusetts, USA) environment with the addition of the sig-
nal processing-, wavelet-, neural network- and data acquisitioning toolboxes.  
 
 
 
Figure 13: Overview of the autonomous auscultation system 
implementation. 
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The first component of the system imports the recorded heart sound and ECG 
signals of each participant into the Matlab environment and saves it in a structure 
whose fields are accessible to the other components. No other information regard-
ing the participants, except their participant identification number, is given to the 
system. Thereafter, the data is denoised using wavelet soft thresholding followed 
by segmentation which splits the recordings into the systole and diastole cycles. 
Analysis of the heart sounds is then performed in the time- and frequency domain, 
followed by the extraction of features. The features are presented as input to the 
classifier which computes the probability of the heart sounds being either normal 
or abnormal. 
4.1 Importing Participant Data 
Data is presented to the autonomous auscultation software in the form of pulse 
code modulated waveform files where, for example, the file named, 
DATA03_1_2.wav, refers to participant number 3, instance 1, part 2. The file 
would contain five synchronised channels of which the first four is the four 
stethoscope recordings and the fifth is the ECG. All the data files of each partici-
pant is read and saved into a unique structure with the wavread function in Mat-
lab.  
As a final step, the amplitudes of all the stethoscope and ECG signals are indi-
vidually normalised to the range [ ]1 1− . Therefore, all the figures representing 
signals in this thesis have a normalised amplitude projected on their y-axis.  
4.2 Denoising the Heart Sound and ECG Signals 
Signal contamination originating from environmental noise and the physical 
constraints of the recording equipment, made the heart sound and ECG signals 
unsuitable for direct analysis. This section describes the different types and 
sources of noise encountered while using the PCG device in the clinical study at 
Tygerberg Hospital. The methods used to prevent signal contamination and the 
implementation of software-based, automatic denoising is also discussed. 
Noise resulting from the design of the PCG device is partly due to the fact that 
the electrodes and stethoscopes are fixed in position relative to a rigid housing. 
This produced a continuous shifting of the position of the electrodes and stetho-
scopes against the participants’ chest, as it expanded and contracted during breath-
ing. Because of this shifting, electrical interference was introduced to the ECG 
and the stethoscopes recorded “rubbing” noises.  
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To overcome these signal contaminations, ultrasound gel was placed on the 
participant’s skin at the stethoscope locations before starting a recording. The gel 
reduced the friction between the skin and stethoscopes, but unfortunately only 
marginally reduced the rubbing noise. To address the electrical noise caused by 
the shifting of position of the ECG electrodes, an electrolyte solution was sprayed 
on the electrodes before placing the PCG device on the participant’s chest. The 
electrolyte significantly increased skin-electrode conduction and reduced much of 
the electrical noise. 
Environmental noise contributed significantly to the total magnitude of the 
noise present in the recordings. The major sources of environmental noise was 
people talking in the hallways, other examinations taking place close by, noise 
and electrical interference produced by other medical equipment in the examina-
tion room and general hospital background noise produced largely by air condi-
tioners. 
Active noise cancellation is incorporated in the electronic stethoscopes to re-
duce most of the effect of environmental noise in the sound recordings 
(Koekemoer, 2008). A second microphone on the opposite side of each stetho-
scope records environmental sounds which a microprocessor then inverts in its 
memory. The stethoscope signal and the inverted environment recording are com-
bined, attenuating environmental noise. The active noise cancellation incorporated 
in the stethoscopes was successful in eliminating background speech from the re-
cordings, but in some cases significant sounds such as the clicking sound of an 
artificial heart valve, was also attenuated.  
Software-based denoising was further necessary for removing any remaining 
noise present in the recordings and to ensure that useful information can be ex-
tracted from them. The procedure followed to perform the software-based denois-
ing is outlined in Figure 14.  
 
 
 
 
 
 
 
 
 
Heart Sounds
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Figure 14: Denoising flow diagram. 
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Electrical interference in the ECG was found to be effectively removed through 
low-pass filtering. The interference is normally of a much higher frequency than 
the waveforms of interest (QRS-complex, T-wave etc.). A 6th order Butterworth 
low-pass filter with a -3dB cut-off frequency at 35 Hz was implemented and 
proved adequate for removing most of the electrical interference. The magnitude 
and frequency responses of the filter are shown in Figure 15 and its effective ap-
plication to denoise a severely corrupted ECG (Figure 16) is illustrated by the re-
sult shown in Figure 17. The filter sufficiently denoised the ECG to allow the 
segmentation algorithm described in Section 4.3 to successfully divide the signal 
into systole and diastole cycles, as is also illustrated in Figure 17. 
 
 
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1-600
-400
-200
0
Normalized Frequency  (×pi rad/sample)
Ph
as
e 
(d
eg
re
es
)
b)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1-600
-400
-200
0
Normalized Frequency  (×pi rad/sample)
M
ag
n
itu
de
 
(d
B
)
a)
Figure 15: Phase- and magnitude response of the 6th order, low-
pass Butterworth filter implemented to denoise the ECG signals. 
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Figure 16: Unfiltered ECG recording. 
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Figure 17: Filtered ECG recording of the example in Figure 16. 
-- ECG signal 
-- Systole Start 
-- Diastole Start 
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Heart sound denoising was accomplished by decomposing the sound with a 
Debouche 7 wavelet at the 5th level. Adaptive threshold selection was based on 
Steins unbiased risk estimate which minimizes the risk of threshold values given 
by a quadratic loss function. The threshold value was then further reduced by a 
factor of 0.3 to ensure that meaningful information was not removed from the sig-
nal. Soft thresholding was applied to all except the approximation wavelet coeffi-
cients. Finally, the coefficients were re-composed, yielding the denoised sound 
shown in Figure 18b). 
4.3 Segmentation 
Segmentation of heart sounds is the process by which a recorded sound is iden-
tified as either being part of systole or part of diastole of the cardiovascular cycle. 
Knowing at which time in the cardiovascular cycle a sound is produced is vital for 
the identification of components in that sound that may indicate a pathology. Af-
ter the sound is segmented it is possible to isolate specific sound events during a 
specific heartbeat and compare them as they reappear in other cycles. 
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Figure 18: a) Recorded heart sound cycle. b) Denoised heart 
sound cycle. 
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To facilitate segmentation an ECG was recorded and synchronised with the 
heart sounds. The ECG is used as a heartbeat monitor wherein the time between 
successive QRS-complexes are taken as entire cycles. The duration of each cycle 
is then used to estimate the start of diastole of that cycle through second order ap-
proximation equations. 
The algorithm implemented to detect the QRS-complexes, outlined in Figure 
19, is based on the methods described by Rangayyan (2002) and Visagie (2007) 
and uses a weighted, squared first derivative operator and a moving average filter. 
The first derivative operator acts as an edge detector as it accentuates areas in the 
signal which are steep and attenuates areas that are level. The MA filter only 
serves to smooth the resulting waveform. 
First, the ECG is downsampled to 100 Hz to increase computational speed. If 
( )x n
 is the ECG signal then,  
 
2
1
( ) | ( 1) ( ) | ( 1)
N
i
y n x n i x n i N i
=
= − + − − − +∑  (4.1) 
represents the signal after applying the first derivative operator. N  is the win-
dowing length and the term, ( 1)N i− + , is the weighting factor. In this case, 
1N =  is used, similarly as in Visagie (2007). Rangayyan (2002) however, used a 
window width of 8N = , but it was found that this resulted in excessive attenua-
tion and incorrect detection of the start of systole.  
After application of the first derivative operator, a MA filter is applied as a 
smoothing function to ( )y n :  
Denoise
Segmentation
Analysis
Identify Peaks
d/dx
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QRS-start
Diastole Start:
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Figure 19: Segmentation flow diagram. 
Stellenbosch University http://scholar.sun.ac.za
34 
 
1
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1( ) ( )
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j
z n y n j
M
−
=
= −∑  (4.2) 
where M is the length of the smoothing window. Setting 3M =  provided suf-
ficient smoothing without eliminating (possibly) relevant peaks.  
The resulting ( )z n , shown in the lower graph of Figure 20, has a waveform 
with clear peaks centred about the QRS-complexes. However, it was observed 
that ( )z n  may, in some cases, still contain artefacts with small amplitudes. There-
fore, all values in ( )z n  smaller than the root mean square (RMS) of ( )z n , calcu-
lated with Equation 4.3, are disregarded. 
 
2
1
1( ( )) ( )
n
i
rms z n z i
n
=
= ∑  (4.3) 
 
 
The next step is to identify the location of the peaks in ( )z n . This is done with 
the findpeaks function built into Matlab, which identifies local peaks in a signal. 
The time histories of successive identified peaks are used to eliminate false peaks 
in ( )z n . False peaks are assumed to occur within 150 ms of the peaks caused by 
the genuine QRS-complexes. Therefore, all the local peaks identified within a 150 
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Figure 20: QRS-peak detection: a) ECG recording. b) ( )z n . 
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ms window are sorted and every peak except the single local maximum in that 
window is discarded. 
The final step in the segmentation process is to calculate an approximate start 
of diastole in all the recorded cardiac cycles. Burke and Nasor (2002) developed 
second order approximation equations for calculating the timing relations of the 
constituents of the human electrocardiogram. These equations describe the timing 
of events in the ECG as functions of the time between successive QRS peaks and 
has been used by previous authors to automate the segmentation of heart sounds 
(de Vos, 2004), (Visagie, 2007). Equations 4.4 and 4.5 were derived from the 
ECG’s of male subjects, but are used in this study for the female participants as 
well. Equation 4.6 was adopted to more accurately calculate the start of diastole in 
the ECG signals. 
 
1/21.65 0.84 0.46Q T R R R RT T T− − −= − −  (4.4) 
 
1/ 21 .2 9 0 .6 6 0 .4 2T w a v e R R R RT T T− − −= − −  (4.5) 
The estimated onset of diastole in each cardiac cycle is then calculated as: 
 
2
Q T T wave
Diastolestart
T T
T − −
+
=
 (4.6) 
where R RT −  is the R-R time interval (in seconds) between successive QRS 
peaks. Diastole startT  is the estimated time after the start of the QRS complex, at 
which diastole begins. Although equations 6 and 7 were derived from normal 
hearts only, it was found to be effective and provided accurate results for all the 
recordings made in this study, including those of abnormal hearts. This was estab-
lished through a visual inspection of the segmentation process on all the re-
cordings. 
The result of the segmentation algorithm applied to a normal heart sound is il-
lustrated in Figure 21. It shows how the heart sound cycles are successfully di-
vided into the systole and diastole parts, even though the ECG signal exhibits a 
significant trend. The segmentation of an abnormal heart sound is shown in Figure 
22. The patient presented a very weak ECG signal corrupted by spurious valleys 
and crests. The performance of the segmentation algorithm can be verified by 
comparing the synchronised ECG trace with the heart sound in Figure 22a). 
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Figure 21: a) Segmented normal heart sound. b) Synchronised 
ECG trace. 
Figure 22: a) Segmented abnormal heart sounds recording. b) 
Synchronised ECG trace. 
-- Signal 
-- Systole Start 
-- Diastole Start 
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4.4 Analysis 
Analysis of the heart sounds is performed to identify the mechanisms involved 
in producing the various components of the sounds and to facilitate the extraction 
of features. The analysis, outlined in Figure 23, consists of two components. The 
first follows a physiological approach, based on discussions with a cardiologist 
(Lubbe, 2009), who has been trained in cardiac auscultation. The second approach 
makes use of the ensemble empirical mode decomposition algorithm (EEMD) to 
analyse the heart sounds and use auto regressive modelling as a quantitative 
measure for constructing features. 
4.4.1 Pathological Approach 
Four cases of heart sounds are considered in the pathological approach: Mitral 
stenosis (MS), mitral regurgitation (MR), aortic stenosis (AS), and aortic regurgi-
tation (AR). These cases are treated separately in this analysis, although cardiac 
patients may present them in any number of combinations. The physical causes 
and the abnormal sounds resulting from these cases are discussed in this section 
and phonocardiograms which illustrate some of these cases are shown.  
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Descriptions
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Energy Ratios
Figure 23: Heart sound analysis flow diagram. 
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Figure 24: Heart sound of mitral regurgitation showing a soft 
S1 followed by a pansystolic murmur. 
Figure 25: Heart sound recording of Aortic stenosis showing a 
crescendo-decrescendo systolic murmur (Visagie, 
2007). 
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Mitral Stenosis 
Mitral stenosis is a heart valve disorder in which the leaflets of the mitral valve 
do not open properly, restricting blood flow from the left atria to the left ventricle. 
This results in an increased pressure gradient of blood across the valve. Common 
causes of MS include rheumatic fever, calcium deposits around the mitral valve, 
radiation treatment of the chest and some medications (Lindberg et al., n.d.). 
The sounds associated with MS starts with an abnormally loud S1 due to the 
mitral valve closing with increased force. An opening snap may be heard during 
S2, due to the forceful opening of the valve. A mid-diastolic, low-pitched, rumble 
is heard after the opening snap which increases in intensity towards the end of di-
astole, as the atria contracts (Lubbe, 2009). The rumble is best heard at the apex of 
the heart with the bell of a stethoscope. The murmur can be accentuated by having 
the patient roll on his or her left side (Lindberg et al., n.d.). 
Mitral Regurgitation 
Mitral regurgitation refers to the leaking (backflow) of blood through the mitral 
valve from the left ventricle to the left atrium. It is a long-term disorder which 
tends to worsen gradually. MR can be congenital or chronic. Causes of chronic 
MR include rheumatic heart disease, atherosclerosis, endocarditis, Marfan syn-
drome, and high blood pressure (Lindberg et al., 2009). 
The sound caused by MR is a soft S1 followed by a pansystolic “thrill” mur-
mur (Figure 24). S3 and an S4 gallop may also be heard during auscultation 
(Lubbe, 2009).  
The sounds produced by ventricular septal defect (VSD) and tricuspid regurgi-
tation (TR) are similar to the case of MR and are therefore not treated separately 
in terms of data analysis. TR is the backflow of blood from the right ventricle into 
the right atrium and VSD is an opening in the cardiac tissue separating the left and 
right ventricles. The murmur of VSD radiates from the 4th inter costal (IC) space 
towards the right, while in the case of MR the murmurs radiate from the 5th IC 
space towards the left armpit (Lubbe, 2009) 
Aortic Stenosis 
Aortic Stenosis refers to the aortic valve not opening fully, restricting blood 
flow from the left ventrical to the aorta. Aortic stenosis can be congenital or 
chronic. Chronic AS mostly occurs in patients who have had rheumatic fever 
(Lindberg et al., 2009). 
The sound produced by AS is a crescendo-decrescendo ejection systolic mur-
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mur (Figure 25). An abnormal click and S4 may also be heard in some cases 
(Lubbe, 2009). 
Aortic Regurgitation 
Aortic regurgitation is the backflow of blood into the left ventricle after it was 
pumped into the systemic circuit. The causes of AR include congenital heart dis-
ease, endocarditis and rheumatic fever (Lindberg et al., 2009).  
The sound produced by AR is a diastolic murmur called an S3 gallop. It can 
usually be heard after S2 and decrescendos towards the end of diastole. Pulmonic 
regurgitation, the backflow of blood into the right ventricle from the pulmonary 
artery, produces sounds similar to that of AR. Pulmonic regurgitation is therefore 
treated together with AR in terms of the data analysis (Lubbe, 2009). 
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4.4.2 Ensemble Empirical Mode Decomposition Analysis 
For analysing nonlinear and non-stationary data, Haung et al. (1998) developed 
a technique known as the Hilbert Haung transform (HHT). At the core of the HHT 
is a method called empirical mode decomposition (EMD) which was originally 
developed to study ocean currents (Huang et al., 1998). The EMD uses a process 
called sifting to decompose a signal into a set of time-energy functions called in-
trinsic mode functions (IMFs). From the IMFs, the instantaneous frequencies 
within the original signal can be derived (as functions of time) through the use of 
the HHT. The resulting time-energy-frequency distribution is called the Hilbert 
Spectrum. Each IMF represents a single oscillatory mode of the original signal, 
which can assist in the identification of structures and the analysis of local events 
embedded in the original signal (Ari & Saha, 2008).  
The sifting process that was used to extract the IMFs from a heart sound re-
cording can be described as follows: 
i. ( )X t  represents a single heart sound cycle. 
ii. Initialize, 1; ( ) ( )i r i X t= = . 
iii. Identify local extrema of ( )r i  and calculate the upper envelope, Ue , and 
lower envelope, Le , using cubic spline interpolation. 
iv. First sifting component, ( )
2
U L
i
e eh r += − . 
v. Redo steps iii & iv, treating h  as the new ( )r i , until stopping criteria are 
satisfied. 
vi. The first IMF is then 
1
c n= . 
vii. Separate 1c  from the data, 1( 1) ( )r i r i c+ = − . 
viii. 1i i= + . 
ix. Extract IMF components 1 2, nc c cK  by repeating from step iii until nc is a 
monotonic function and no more IMFs can be extracted. 
Figure 26 shows the upper and lower envelopes (step iii) computed for S1 of a 
normal heart sound. The mean of these envelopes is used to compute the IMFs in 
steps iv to vi. The criteria for stopping the sifting process in step v can be related 
to the definition of an IMF. That is (a) the number of extrema and zero crossings 
must be equal or differ at most by one and (b) the IMF must be symmetrical with 
respect to a zero mean (Huang et al., 1998). However, in practice these conditions 
can lead to over sifting, eliminating physically meaningful information from the 
IMF. Haung et al. (1998) therefore proposed a technique in which the standard 
deviation of the current and previous sifting components is evaluated and if found 
to be below a threshold of 0.3, the sifting is stopped and the previous h  is taken as 
the new IMF.  
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Figure 26: Computation of the intrinsic mode function: the 
upper and lower envelopes of the local maxima and 
minima of S1. 
-- Heart sound 
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Figure 27: a) PCG device recording of a single heart sound 
cycle. b) The first intrinsic mode function. 
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By summing all the IMF components, the original signal can be reproduced: 
 
1
( )
n
i
i
X t c
=
=∑  (4.7) 
The first IMF component, 1c , of a single heart sound cycle is shown in Figure 
27b) and the sound from which it was derived, in Figure 27a). 
The important properties of the EMD method are: 
1. EMD is an adaptive data analysis method that is based on the characteris-
tics of the data alone.  
2. EMD makes no a priori assumptions about the data. 
3. EMD acts as a dyadic filter bank when applied to a series of white 
(Gaussian) noise (Flandrin et al., 2004). 
A major disadvantage of EMD, however, is the frequent appearance of mode 
mixing (Wu & Haung, 2009). Mode mixing occurs when dissimilar scales of a 
signal appear in the same IMF or when similar scales are spread over various 
IMFs. Therefore, to address this problem, an important improvement to the EMD 
was proposed by Wu and Haung (2009) by transforming it into a noise-assisted 
data analysis method called ensemble empirical mode decomposition (EEMD). 
EEMD takes advantage of the characteristics of white noise to provide a frame of 
reference for the original EMD. Finite amplitude white noise is added to the signal 
to uniformly fill its whole time-frequency space. Due to the filter bank properties 
of EMD, the signal components are subsequently projected on the proper scales of 
reference established by the white background noise.  
The EEMD creates an ensemble of white noise added signals by adding a dif-
ferent series of white noise numerous times to the original signal. The thi member 
of the ensemble would then be: 
 
( ) ( ) ( )i ix t x t w t= +  (4.8) 
where ( )x t  is the original recorded signal and ( )iw t  is the thi  series of added 
white noise. In the mean of a sufficiently large ensemble, the white noise cancels 
out, leaving only the persistent part of the signal. The outcome of this approach is 
that the components of similar scales are more likely to gather in the same IMFs, 
reducing the effects of mode mixing (Wu & Haung, 2009). 
The EEMD modification to the original EMD can be outlined as follows: 
i. Add a white noise series with an amplitude equal to the ratio, Nstd , 
times the standard deviation of the original heart sound signal to obtain 
( )iX t . 
ii. Decompose ( )iX t  into a set of n  IMFs, ,1 ,2 ,, , ,i i i nc c cK  using EMD. 
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iii. Repeat i and ii, each time with a different white noise series, to obtain 
i NE=  sets of IMFs, where NE  is a sufficiently large number. 
iv.  Calculate the mean of the ensemble of IMFs to obtain the final result. 
The values for Nstd  and NE  were chosen as 0.1 and 100 respectively. These 
values are based on experimentation and the implementations of the method by 
Wu and Haung (2009). Generally, the larger the ratio of amplitude of the added 
white noise, Nstd , the more ensembles members, NE , is required, but at in-
creased computational cost. However, making Nstd  too small may not provide 
the alterations in the signal that the EMD depend upon to properly perform the 
decomposition. 
The EEMD analysis applied to a normal heart sound is shown in Figure 28. 
The EEMD was able to successfully capture the first heart sound, S1, in the first 
IMF component with the second heart sound initially appearing only in the second 
IMF. Comparatively, the EEMD analysis performed on an abnormal heart sound 
with diastolic murmurs and lower pitched systolic murmurs is shown in Figure 29. 
In this figure, the diastolic and systolic mummers are encircled in the IMF com-
ponents. Especially the diastolic murmurs are clearly distinguishable from the first 
and second heart sounds in these IMFs. These figures illustrate the usefulness of 
the EEMD method, particularly for the purpose of detecting abnormalities in heart 
sounds.  
The IMFs containing the most physically relevant and meaningful components 
of the heart sound recording is not necessarily the first or second. In some of the 
recordings the first IMF would only contain small amplitude, high frequency 
noise components which are irrelevant to the analysis. Therefore, a method has 
been devised with which to automatically judge the relevance of IMF compo-
nents. 
The method involves calculating the correlation coefficient, ρ , between the 
heart sound and each IMF: 
 
,
( , )
sound imf
sound imf
COV sound imfρ
σ σ
=
 (4.9) 
where the nominator is the covariance between the heart sound and the IMF in 
question and the denominator contains the standard deviations of the heart sound 
and IMF. The three IMFs which yield the highest correlation to the heart sound 
from which it was decomposed, is then chosen as significant for further analysis 
while the others are discarded. Determining which IMFs are significant is impor-
tant as it significantly reduces the amount of irrelevant information input to the 
classification system. 
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Figure 28: The EEMD method applied to a normal heart sound: 
a) Normal heart sound. b) The first IMF component. c) The 
second IMF component. 
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Figure 29: The EEMD method applied to an abnormal heart 
sound: a) Abnormal heart sound with systolic and diastolic 
murmurs. b) The first IMF component. c) The second IMF 
component. 
-- Heart Sound 
-- Systole Start 
-- Diastole Start 
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4.4.3 Auto Regressive Model 
In order to characterise the spectral information in the intrinsic mode functions 
extracted with the EEMD analysis, autoregressive modelling was performed. An 
auto regressive model was computed for every systole and diastole cycle of each 
of the three IMFs which has been identified to contain significant information. 
The performance of the modelling was judged based on how well the classifica-
tion scheme separated the normal and abnormal heart sound classes. 
Auto regressive modelling forms part of the parametric group of methods for 
estimating the power spectra of linear systems. These methods are designed for 
use where only short data records are available, which makes them ideal for char-
acterising IMFs. Advantages of auto regressive models include the ease of calcu-
lating model parameters and its ability to represent spectra with narrow peaks, or 
resonances (Proakis & Manolakis, 2007). 
The auto regressive model parameters were estimated using the unconstrained 
least squares method as is given by Proakis & Manolakis (2007). This method was 
chosen as its performance characteristics have been found to be superior to most 
other methods and it is insensitive to problems related to frequency bias and spu-
rious peaks (Proakis & Manolakis, 2007).  
The auto regressive model can be defined as: 
 
1
p
t i t i
i
X Xϕ
−
=
=∑  (4.10) 
where tX  is the signal to be modelled, 1 , , pϕ ϕK are the model parameters, and 
p is the model order. Selecting the model order, p , is an important part of auto 
regressive modelling. Proakis & Manolakis (2007) suggests that as a general rule 
if p  is selected too low a highly smoothed spectrum is obtained. While, if p  is 
selected too high false low-level peaks may appear in the spectrum. Model orders 
of 5,6, 20p = K  were evaluated by using the model parameters as features. The 
classification performance was then computed for each model using cross-
validation and the leave-one-out method, as discussed in Section 4.6.4. It was 
found that using 12p =  resulted in superior classification performance compared 
to other models and was therefore used in the final implementation.  
4.5 Feature Extraction 
The features extracted from each recorded cardiac cycle ultimately serve as in-
put to the statistical classification system which detects if cardiovascular disease 
is present. The choice and design of these features therefore have a direct influ-
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ence on the performance of the classification process. Through the use of the 
analysis methods presented in previous chapters, the features are designed to con-
tain the elemental characteristics of the recorded heart sounds.  
The features in the final implementation of the autonomous auscultation system 
amounted to 7 pathology-based time domain features and 72 features based on 
EEMD. The latter consist of 12 auto regressive model coefficients computed sepa-
rately for systole and diastole for each of the three significant IMFs. 
A total of 79 features per participant were therefore used as input to train and 
simulate the classification scheme. 
4.5.1 Time domain, pathology-based Features 
Energy ratios of different parts of the heart sound cycle have been identified 
for providing information relevant to the detection of CVD. The choice of energy 
ratios is based on discussions with a cardiologist, who has training in cardiac aus-
cultation (Lubbe, 2009), and follows from the pathological analysis of Section 
4.4.1. Once the energy ratios are calculated they are each used as input to the clas-
sification scheme. 
Feature extraction starts by dividing each systole and diastole part of each heart 
sound cycle into three equal pieces as illustrated in Figure 30 and Figure 31. The 
average energy, calculated with Equation 4.3, contained in each of the sections is 
labelled as either 1, ,3ES K  for systole or 1, ,3ED K  for diastole. The identified energy 
ratios are listed in the equations shown in Table 4.  
Systolic Feature Diastolic Feature Comparison of Systolic 
and Diastolic regions 
1
1
2 3
ESF
ES ES
=
+
 
1
3
2
EDF
ED
=
 
2 3
2
1
ED EDF
ES
+
=
 
1
7
2
ESF
ES
=
 
 
1
4
1
ESF
ED
=
 
  
2 3
5
2 3
ES ESF
ED ED
+
=
+
 
  
1 2 3
6
3
ES ES ESF
ED
+ +
=
 
Table 4: Pathology-based, time domain features. 
Stellenbosch University http://scholar.sun.ac.za
48 
 
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
time [s]
am
pl
itu
de
Section 1 Section 2 Section 3
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
time [s]
am
pl
itu
de
Section 3Section 2Section 1
Figure 30: Division of systole heart sound into three sections. 
Figure 31: Division of diastole heart sound with murmurs into 
three sections. 
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4.5.2 Auto Regressive Model Features 
The 12th order auto regressive model parameters described in Section 4.4.3 are 
calculated for each systole and diastole part of the each recorded cardiac cycle. 
This is done for all three of the significant IMFs derived with the methods of Sec-
tion 0. The result is a total of 72 features for every recorded cardiac cycle for 
every participant. 
4.5.3 Feature Averaging over Cardiac Cycles 
Utilizing each recorded cardiac cycle’s features as a separate data point input to 
the classification scheme resulted in poor classification performance and subse-
quent separation between of the normal and abnormal classes. This is thought to 
be caused by the extreme cycle-to-cycle variation exhibited by the heart sound 
components and the fact that an unequal amount of cardiac cycles are available 
for each of the participants.  
Therefore, the statistical median is calculated over the features of all the re-
corded cardiac cycles of each participant. The median, η , which minimizes the 
average and absolute deviations of a dataset, is considered a more representative 
measure of the locality of a dataset with a skew probability distribution than the 
mean, µ , which is generally used(Steyn et al., 2004). The median is defined statis-
tically as the value, η , for which the probability is: 
 
( ) 0.5P X η≤ =
 (4.11) 
X , in this case, is the vector containing the values of a particular feature of the 
all recorded cardiac cycles of a single participant. Averaging over the cardiac cy-
cles to produce a single data point per participant was found to generally yield 
better classification results than using each cycle as a separate data point. 
4.6 Classification using Artificial Neural Networks 
Classification is the task of using computer algorithms to autonomously find 
patterns in data, which is a fundamental challenge. Its main concern is the action 
of organizing data into different categories based on those patterns. A well-known 
application of this process is handwriting recognition, found on many handheld 
computers, where a handwritten digit is recognised and its identity is produced 
0, ,9K
 as the output (Bishop, 2006). 
Given an input vector x  the goal of classification is to assign it to one of K  
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discrete classes, kC , where k = 1,…,K . The classes are generally disjoint so that 
each input can be assigned to only one class (Bishop, 2006). In this study, each 
recorded participant is represented by a single, unique input vector, x , whose 
elements are the features described in the previous sections. The number of ele-
ments in x  determines the dimensionality, D , of the input space.  
The target variable t is the vector we wish to predict and is a binary representa-
tion of the class to which each individual observation, x , is mapped. In the case 
of a two-class problem, such as implemented in this study,  
 
0 1
1 0
t
 
∈ 
 
 (4.12) 
where [ ]1 0=t  represents class 1C  (normal, no CVD) and [ ]0 1=t  repre-
sents class 2C  (CVD is present). 
The process of classification is similar to that of fitting a curve to data. The in-
put data is fit to a combination of functions through training to produce a desired 
output. The classifier divides the feature space of the problem into decision re-
gions whose boundaries are called decision boundaries forming 1D −  dimen-
sional hyperplanes within the D -dimensional input space. The profile of these 
boundaries is determined during training, whereby an unknown data point is clas-
sified, depending on its location in the feature space, relative to the decision 
boundaries. 
Using linear combinations of fixed basis functions for classification has advan-
tages of useful analytical and computational properties, but presents a significant 
limitation to their application on large scale problems. This limitation arises due 
to what is commonly referred to as the curse of dimensionality. As an example, 
consider the task of polynomial curve fitting. To fit a 3rd order polynomial to D  
input variables would require 3D  independent coefficients. As D  increases, the 
number of coefficients increase proportional to 3D . Similarly, fitting a polyno-
mial of order M , the number of coefficients would increase by MD . This exam-
ple illustrates how the practical application of linear classifiers is limited to small 
scale problems due to this curse of dimensionality (Bishop, 2006). 
To overcome the challenges arising from the high dimensionality of large scale 
problems, it is necessary to adapt the basis functions to the data. An attractive ap-
proach is to fix the number of basis functions in advance, but allow their parame-
ters to be adaptive during training. According to Bishop (2006) the most success-
ful model of this type in pattern recognition is the feed-forward neural network, 
and is therefore implemented in this study. 
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4.6.1 Network Construction 
The classification scheme implemented in this study is an ensemble of three-
layer perceptron feed-forward neural networks. Each neural network consist of 
interconnecting groups of functions called neurons, which process information 
and then passes it to the other neurons connected to it. The neurons are grouped 
into different layers of which the first is the input layer and consists of the features 
for each participant. The second layer is a hidden since its inputs and outputs are 
not used directly. The third layer is the output layer and consists of 2 neurons, one 
for each class. Its output is the final decision output of the network.  
During experimentation with different features it was found that fixing the 
number of neurons in the hidden layer to 1.3 times the number of features gener-
ally produced good cross-validation results through the leave-one-out method de-
scribed in Section 4.6.4. This ratio was also used in the final implementation of 
the system to determine the number of neurons in the hidden layer.  
The overall network function governing the output, ky , of each ensemble 
member is given by Equation 4.13 and is illustrated graphically in Figure 32.  
 
(2) (1) (1) (2)
1 1
( , , )
M D
k kj ji i j k
j i
y f w h w x b b
= =
  
= + +  
  
∑ ∑x b w  (4.13) 
The number of outputs for each network is given by 1, ,k K= K  in Equation 
4.13, where 2K =  represents the number of classes to which the input data, x , 
will be classified. The number of neurons, M , in the hidden layer is given by 
1, ,j M= K . The dimensionality of the input data is given by 1, ,i D= K , where 
D
 represents the number of features for each participant. The functions f  and h  
are the activation functions of the neurons. The output layer of each network is 
unconstrained with the linear activation function, f , given by Equation 4.15. The 
activation function, h , of the neurons in the hidden layer is the hyperbolic tangent 
sigmoid function of the form given by Equation 4.14. 
 
1( )
1 exp( )h x x= + −  (4.14) 
 
( )f x x=
 (4.15) 
The adaptable parameters of each network in the ensemble are the weights and 
biases. For the neurons in the output layer, these parameters are represented by 
(2)
kjw  and (2)kb  in Figure 32 and similarly for the neurons in the hidden layer they 
are represented by (1)jiw  and (1)jb . The construction of each network in the final en-
semble implementation consisted of 103M =  hidden neurons and 79D =  dimen-
sions in the feature space. 
 
Stellenbosch University http://scholar.sun.ac.za
52 
 
 
 
 
 
 
 
 
 
Each ensemble neural network member is initialised before it is trained using 
the Nguyen-Widrow method (Nguyen & Widrow, 1990). This method generates 
initial weights and biases in such a way that the active regions of each layers’ 
neurons are distributed more or less evenly over the input space. The advantage of 
this method over a solely random initialisation is that training is performed 
considerably faster. 
4.6.2 Ensemble Neural Networks 
Ensemble neural networks have been applied in many fields and have been 
shown to generally give more accurate results compared to unitary 
networks(Bhatikar et al., 2004). Ensembles are typically used when the data is too 
complex to be modelled by a single network. The objective of the ensemble is to 
combine the individual outputs of each neural network member to obtain better 
generalisation.  
In this study an ensemble of 99 neural network members is implemented to ob-
tain a final decision output and confidence. The number of members was chosen 
as large as possible without severely affecting computation performance. A choice 
of 100 members adequately fulfilled this requirement, but was reduced to the 
closest odd number to prevent decision ties. Liu et al. (2004) implemented ensem-
ble artificial neural networks in their study of classifying gene expressions and 
found that it repeatedly provided a better accuracy than a single network. Bhatikar 
et al. (2004) implemented a decision-of-experts ensemble ANN classification 
scheme in their cardiovascular screening system for paediatrics and reported a 
sensitivity and specificity of 88% and 83% respectively. 
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Figure 32: Artificial neural network graphical representation. 
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The ensemble decisions are combined based on the number of times a particu-
lar participant was classified to a certain class. For example in Table A1, partici-
pant 3 was classified by 87 ensemble members as normal and only by 12 as ab-
normal. The final output is thus normal with a confidence of 87.9%. The confi-
dence is calculated as a percentage with the formula, 
 
#
#
decisions in output class
confidence
ensemble members
=  (4.16) 
Simulating each participant with multiple ensemble members was necessary to 
obtain a measure of how well the features separated him or her into a particular 
class. Simulating the masked participant only once could produce an unrealistic 
result as he or she might have been classified correctly (or incorrectly) only by 
chance. Therefore, re-simulating 99 times provided a decision confidence on the 
classification accuracy of the entire system on each participant. 
4.6.3 Training 
Supervised training is applied to the network and involves adapting the weights 
and biases in order to improve the match between the network output and the tar-
get values assigned for each of the input vectors.  
The backpropagation algorithm (Bishop, 2006), which sends information 
backward and forward through the network, is used to calculate error gradient in-
formation. Using these gradients, the weights and biases are adapted with the 
scaled conjugate gradient descent optimization algorithm to minimize the squared 
differences between the outputs and targets.  
Weight and bias learning was performed with the gradient descent with mo-
mentum algorithm (Vanderplaats, 2005). The learning rate was set to 0.01 and the 
momentum term to 0.9. A training goal of 51 10−×  was used. Network perform-
ance was evaluated during training using the mean-squared-error performance 
function.  
The training data presented to each ensemble neural network member was di-
vided into two parts: 90% train and 10% validate. The 10% validation is used dur-
ing training to automatically fine tune the network parameters and is not related to 
the cross-validation procedure discussed in Section 4.6.4. 
4.6.4 Leave-one-out Cross-Validation 
Testing a classification scheme generally yields the likelihood that a future pa-
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tient will be recognised and classified correctly. Cross-validation is the process of 
testing the already trained network with data that has not been used for training 
and is hence unknown to the network. The cross-validation techniques discussed 
in this section is not related to the verification and validation of software for mis-
sion critical applications. It is, however, necessary to ensure that the ensemble 
neural network has not overfitted the training data, but sufficiently generalized 
over the natural variations between individuals.  
The customary method for testing a classification scheme, when large quanti-
ties of data are available, involves dividing the data into two subsets. The first set 
is used for training while the second is used as a cross-validation dataset with 
which to test the entire system. The advantage of this method is that it requires 
only a few simulation runs, but it is severely dependent on the quantity of avail-
able test data. The test dataset also needs to be large enough to be representative 
of the population from which it is drawn; otherwise the performance result of the 
network will not be physically realistic. Unfortunately, due to the limited quantity 
of data available in this study, such testing of the system could not be performed. 
Therefore, the results from cross-validation are used instead to determine the 
overall system performance.  
Cross-validation is a technique for determining how a classification scheme 
will generalise over an independent data set. The technique involves partitioning 
data into subsets, where one subset is used to train the classifier and the other is 
used as a validation dataset. 10-fold cross-validation is commonly employed 
whereby the data is divided subsets containing 10 data points each. Training is 
done on 9 data points and the classifier is tested on the remaining one. The aver-
age accuracy obtained over all the subsets is then reported.  
The leave-one-out cross-validation method is used to circumvent the constraint 
caused by the lack of sufficient testing data in this study. The advantage of this 
method above methods such as 10-fold or 5-fold cross-validation is that almost 
none of the potential training data is used for cross-validation. However, the 
method is computationally expensive since the classifier needs to be re-trained 
and simulated as many times as there are data points (participants in the clinical 
study). Guo et al. (1994) implemented the leave-one-out method to evaluate the 
performance of their ANN classifier that was designed to assist in the auscultation 
of bioprosthetic heart valves (Guo et al., 1994). Bhatikar et al. (2004) developed a 
screening system for paediatrics based cardiac auscultation and used the leave-
one-out method to evaluate its performance (Bhatikar et al., 2004). 
The leave-one-out cross-validation algorithm and ensemble implementation is 
shown in Figure 33. The method starts by masking the data of the first participant, 
using all the other participants as training data. Then, the first ensemble member 
is trained and simulated with the masked participant. The inner loop re-initializes 
the network using the Nguyen-Widrow method, creating the second ensemble 
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member, which is then re-trained and used to re-simulate the masked participant. 
The inner loop now iterates until the masked participant has been simulated with 
all the ensemble members. The second participant is now masked and a new train-
ing dataset is formed. This process is repeated until every participant has been 
simulated with all the ensemble members. 
 
 
Classification
Feature
Extraction
Neural Network
Construction
Train Input: all features
 except masked patient m
for m = 1:size(patients)
Nguyen-Wodrow
Initialize Neural Network
for count = 1:99
Train Neural Network
Classify patient m
Store output
Calc Final Result
for patient m
if end loop
DIAGNOSIS
Normal / Abnormal
% Confidence
if end loop
Figure 33: The leave-one-out cross-validation and ensemble 
neural network algorithm. 
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4.7 Graphical User Interface 
A graphical user interface (GUI) was created as part of the development of the 
autonomous auscultation system. It was designed to enable fast and easy verifica-
tion of the functioning of all the sub-algorithms on any of the participants. Figure 
34 show how the GUI is used to verify that the segmentation algorithm correctly 
segmented the heart sound of a particular participant. Figure 35 illustrates how the 
GUI assists with the analysis of the heart sounds by displaying the result of the 
EEMD algorithm on the heart sounds. 
The GUI can also be used for displaying phonocardiogram information for the 
purpose of providing decision support to clinicians. Further development of the 
GUI could even provide the potential for it to be incorporated into current elec-
tronic medical record systems in healthcare facilities to graphically portray patient 
information. 
 
 
Figure 34: Autonomous auscultation system graphical user 
interface showing the heart sound segmentation process. 
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4.8 Chapter Summary 
This chapter discusses the detail design and implementation of the components 
constituting the autonomous auscultation software system. These components in-
clude importing data, denoising, segmentation, feature extraction and classifica-
tion. Evaluation of the system through the leave-one-out cross-validation method 
is also described. The chapter concludes with a description of the graphical user 
interface which has been designed to visually verify the functioning of all the sub-
components of the system. 
 
 
Figure 35: Autonomous auscultation system graphical user 
interface showing the ensemble empirical mode decomposition 
analysis of a heart sound. 
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5. RESULTS AND FINDINGS 
This chapter discuss the performance results of the autonomous auscultation 
system. Through implementation of the leave-one-out cross-validation method 
discussed in Section 4.6.4 a decision output was obtained for every participant. 
Combining of the ensemble neural network members’ outputs to obtain a final 
decision is illustrated and is related to the echocardiograph used as the benchmark 
diagnosis (gold standard). A description of the overall performance of the system 
is presented through sensitivity, specificity, accuracy, predictive values and likeli-
hood ratios. Finally, a comparison with the results of other, similar, studies is 
drawn. 
5.1 Individual Participant Results 
The leave-one-out cross-validation results were used during development of 
the autonomous auscultation system to test its performance as well as to verify the 
functioning of all its subcomponents. If any of the processes prior to classification 
malfunctioned, it was expected to be reflected in these outputs or at worst by the 
decision confidences. This assumption is founded on the fact that the network is 
cross-validated with data which has not been used for training.  
The final results of the autonomous auscultation system on participants re-
corded with the PCG device are given in Table A1 and similarly, those recorded 
with the Auscultation Jacket are listed in Table A2. These tables summarise the 
result of the echocardiograph on each participant, the final cross-validation output 
of the autonomous auscultation system and a confidence percentage on the deci-
sions. An extract from Table A1 is shown in Table 5 to illustrate the results. For 
example, participant #56, in Table 5, presented an abnormal heart condition which 
was diagnosed as aortic stenosis (AS) by the echocardiograph (2nd and 3rd col-
umns). The number of ensemble members that classified each participant as either 
class 1 (normal) or class 2 (abnormal) is listed in the 4th and 5th columns. Partici-
pant #56 was classified by 12 members as normal and by 87 as abnormal. This 
participant is therefore identified as abnormal with a final classification output of 
[ ]0 1  and a confidence of 87.9%. The confidence is calculated with Equation 
4.16 as a percentage based on the number of neural network members that cor-
rectly classified the participant. If the confidence value is within ± 5% of 50%, 
then the diagnosis can be regarded as inconclusive. 
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The incorrectly classified participants are printed in red in Tables A1 and A2. 
For comparison, the incorrectly classified participant #54 in Table 5 was misclas-
sified by most of the ensemble members largely because the pitch of the clicking 
sound of his prosthetic mitral valve (MV) falls outside the frequency response of 
the electronic stethoscopes. In this case, 61 ensemble members falsely identified 
the participant as normal and only 38 as abnormal. Therefore, the final classifica-
tion output [ ]1 0  signifies that the system identified the participant (falsely) as 
normal.  
To illustrate the raw ensemble neural network outputs for each participant, the 
outputs of participant #35 (Appendix A, Table A2) is listed in Table A3. An ex-
tract from Table A3 is shown below in Table 6. The second and third columns 
contain the outputs for each of the 99 ensemble members. Each member’s final 
decision (4th and 5th columns) and is based on which of these outputs are the larg-
est.  
Ideally the output of each member should be close to either [ ]1 0  or [ ]0 1 , 
like that of member #2. However, some outputs are problematic such as those of 
members #1 and #21 in Table 6. In future work, such problematic outputs could 
be addressed by constructing the network to only have a single neuron in the out-
put layer, or by assigning adaptive weights to the members. If a member then out-
puts such a problematic result, its influence on the final decision would be low-
ered by automatically adjusting its weight value.  
 
Table 5: Extract from cross-validation study. 
Table 6: Ensemble neural network output and decisions. 
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5.2 Autonomous Auscultation System Performance 
The performance of the autonomous auscultation system was evaluated sepa-
rately for the data recorded by the PCG device and the Auscultation Jacket. Due 
to the hardware differences between the two devices, such as bell and diaphragm 
materials and stethoscope positioning, the characteristics of their sound recordings 
were fundamentally different. Consequently, when their recordings were pre-
sented collectively to the autonomous auscultation system, the system was unable 
to differentiate between the normal and abnormal heart sounds. But, when pre-
sented independently, differentiation between the normal and abnormal classes 
were achieved. 
The diagnostic value of any medical test, when compared to a gold standard, is 
conventionally stated in terms of the sensitivity, specificity, predictive values, ac-
curacy and likelihood ratios (Greenhalgh, 1997). Each of these performance 
measures provide a unique insight into the screening capability of the medical test 
and is necessary to allow different diagnostic systems to be compared. The nota-
tion for expressing these performance measures are listed in Table 7 in the form of 
a confusion matrix. The rows represent the gold standard and the columns are the 
cross-validation test results. In the case of this study, the number of true negatives 
(#TN) is the number of normal, healthy participants classified correctly by the 
autonomous auscultation system as normal, whereas the number of false negatives 
(#FN) is the number of abnormal participants classified incorrectly as normal. 
Similarly, the number of true positives (#TP) is the number of abnormal patients 
(CVD present) classified correctly by the autonomous auscultation system as ab-
normal and the number of false positives (#FP) is the number of normal patients 
classified incorrectly as abnormal. 
 
normal (gold standard) #TN #FP 
abnormal (gold standard) #FN #TP 
 normal (test) abnormal (test) 
 
Confusion matrices of the results from the leave-one-out cross-validation of 
Section 4.6.4 for the Auscultation Jacket and PCG device are shown in Tables 8 
and 9. For example, Table 8 illustrates how the autonomous auscultation system 
classified 30 healthy participants correctly and 4 incorrectly, whereas 23 abnormal 
participants were classified correctly and 5 incorrectly. 
Table 7: Notation for expressing the result of a validation, 
screening, or diagnostic test (Greenhalgh, 1997). 
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normal (echocardiograph) 30 4 
abnormal (echocardiograph) 5 23 
 normal Abnormal 
 
normal (echocardiograph) 28 3 
abnormal (echocardiograph) 5 16 
 normal Abnormal 
 
The measures used to describe the performance of the developed autonomous 
auscultation system in this study are summarised in Table 10. Since these values 
were calculated by comparison with the echocardiograph, they can be used to di-
rectly compare this study to other, similar studies. 
The sensitivity (Table 10) is the fraction of abnormal participants classified 
correctly as abnormal. It is a measure of how well the system identified CVD in 
the heart sounds of the participants in the study. The specificity is the fraction of 
normal participants classified correctly as normal and is a measure of how well 
the autonomous auscultation system excluded participants without CVD. The ac-
curacy of the autonomous auscultation system describes the proportion of all the 
participants that was classified correctly. The sensitivity, specificity and accuracy 
measures, however, are insensitive to the prevalence of CVD in the test partici-
pants. Also, they do not give information regarding the probability that a new, un-
known patient will be diagnosed correctly, unless the proportion of abnormal to 
normal participants in the study is similar to that of the real world (Altman & 
Bland, 1994). Therefore, predictive values, also referred to as the post-test prob-
abilities, are used as they depend crucially on the prevalence of CVD in the par-
ticipants being tested.  
The positive predictive value is the proportion of participants that tested posi-
tive for CVD by the autonomous auscultation system and who are correctly diag-
nosed. It represents the probability that if a new, unknown, patient is identified as 
abnormal (CVD present), that he or she really is abnormal. Similarly, the negative 
predictive value is the proportion of participants that tested negative (CVD not 
present) by the autonomous auscultation system, when they really are normal.  
Table 8: PCG device confusion matrix. 
Table 9: Auscultation Jacket confusion matrix. 
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The usefulness of the autonomous auscultation system as a screening test can 
further be determined through the use of likelihood ratios computed from the re-
sults of the leave-one-out cross-validation study (Greenhalgh, 1997). Likelihood 
ratios are alternative statistics to the sensitivity and specificity and are similarly 
used to summarise the diagnostic accuracy of a screening test (Deeks & Altman, 
2004).  
The positive likelihood ratio gives an indication of how much more likely a 
positive test is to be found in a future patient with CVD, than in a patient without 
it. Similarly, the negative likelihood ratio shows how much more likely a negative 
test result will be found in a patient without CVD, than in an abnormal patient 
(Greenhalgh, 1997). Generally, the farther the value of a likelihood ratio is from 
1, the stronger is the evidence for the presence or absence of CVD. A positive 
likelihood ratio of above 10 and a negative ratio of below 0.1 are generally re-
garded as strong enough evidence to rule a diagnosis based only on the test result 
(Deeks & Altman, 2004). 
Knowing how the developed autonomous auscultation system predicts the risk 
of CVD is essential to clinical practice. The sensitivity, specificity and predictive 
values cannot be used for this as they are only relevant beyond a study if the par-
ticipants form a suitable random sample of the population (Deeks & Altman, 
2004). The likelihood ratios provide a solution to this as they can be used to calcu-
late the probability of abnormality. For this reason, many clinicians prefer the use 
of likelihood ratios as performance measures to sensitivities and specificities 
(Deeks & Altman, 2004). By relating the prior probability and the test probabili-
ties through Bayes’ theorem, shown in Equation 4.17, the posterior test probabil-
ity can be calculated from the likelihood ratios (Bishop, 2006).  
 
( | ) ( )( | ) ( )
k k
k
p C p C
p C
p
=
x
x
x
 (4.17) 
The prior probability, ( )kp C , that a patient has CVD, before he or she is tested 
with the autonomous auscultation system can now be taken into account by multi-
plying the likelihood ratio with the prior probability. Since the probability of x ,
( )p x , cancels out in Equation 4.17 with a normalisation constant, this multiplica-
tion yields the posterior odds, ( | )ko C x , of a positive or negative diagnosis. The 
posterior probability, ( | )kp C x , can then be calculated using Equation 4.18. This 
posterior indicates the probability that the test patient is indeed positive or nega-
tive, given a prior probability and a diagnosis from the autonomous auscultation 
system (Deeks & Altman, 2004). 
 
1( | ) (1 ( | ))k k
p C
o C
=
−
x
x
 (4.18) 
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Performance 
Measure Formula PCG device 
Ausculta-
tion Jacket 
Sensitivity #
(# # )
TP
TP FN+
 
82.1% 76.2% 
Specificity #
(# # )
TN
TN FP+
 
88.2% 90.3% 
Accuracy # #
(# # # # )
TP TN
TP FN TN FP
+
+ + +
 
85.5% 84.6% 
Positive predictive 
value 
#
(# # )
TP
TP FP+
 
85.2% 84.2% 
Negative predictive 
value 
#
(# # )
TN
TN FN+
 
85.7% 84.8% 
Likelihood ratio of 
a positive test (1 )
Sensitivity
Specificity−  6.98 7.87 
Likelihood ratio of 
a negative test 
(1 )Sensitivity
Specificity
−
 
0.20 0.26 
 
The sensitivity and specificity results obtained in this study with the autono-
mous auscultation system are comparable with many similar studies. Bhatikar et 
al. (2004) reported sensitivity and specificity values of 88% and 83% respectively 
with their ensemble neural network system to autonomously screen for CVD in 
paediatrics. Their software system uses recordings made with a standard elec-
tronic stethoscope to screen for CVD (Bhatikar et al., 2004). Sinha et al. (2007) 
reported an accuracy of 95% for their software system which autonomously 
screens phonocardiograms for pathological conditions (Sinha et al., 2007). Leung 
et al. (2000) reported sensitivity and specificity values of 97% and 94% respec-
tively in their study of automatic differentiation between normal and pathological 
phonocardiograms (Leung et al., 2000). Turkoglu et al. (2002) developed a system 
to autonomously diagnose cardiac valvular disease through auscultation and re-
ported a classification accuracy of 94% in their clinical study (Turkoglu et al., 
2002). Chauhan et al. (2008) reported an accuracy of 90% for autonomously de-
tecting diastolic murmurs in heart sounds using their automated screening system 
(Chauhan et al., 2008). 
Unfortunately, references reporting likelihood ratios with regards to the clinical 
testing of similar autonomous auscultation systems could not be found in litera-
Table 10: Performance of the autonomous auscultation system 
calculated by comparison with the echocardiograph in 
a cross-validation study. 
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ture. However, the likelihood ratios obtained during this study are sufficiently 
dispersed from 1 to indicate a high probability the system will identify a future 
abnormal patient as abnormal and discard a negative patient.  
The combination of the results in Table 10 indicates that the developed 
autonomous auscultation system can be useful as a diagnostic screening tool with 
high probabilities for producing accurate positive and negative diagnoses. 
5.3 Performance Comparison with a Cardiologist 
As part of the clinical study to validate the developed autonomous auscultation 
system, each participant was inspected by a resident cardiologist at Tygerberg 
Hospital. The cardiologist only had access to a stethoscope with which to formu-
late his diagnosis and did not view the ECG or echocardiograph of the participants 
prior to noting his findings. The findings of the cardiologist examinations are 
listed in Table A4 along with the participant details and echocardiograph diagno-
sis.  
In comparison with the echocardiograph, the cardiologist diagnosed all the ab-
normal patients correctly as abnormal, but misdiagnosed one healthy participant. 
The cardiologist therefore scored a sensitivity of 100% and specificity of 96.6% in 
the clinical study. This is much better than the sensitivity and specificity obtained 
by the developed autonomous auscultation system (82% and 88% respectively). 
However, given the fact that the cardiologist has auscultation experience on likely 
several hundreds of patients and the autonomous system could only rely on the 
recordings of about 60 volunteers, significant improvement in the system’s per-
formance can be expected with the availability of more training data. 
5.4 Chapter Summary 
This chapter discussed the results obtained with the autonomous auscultation 
system in the clinical study at Tygerberg Hospital. Calculation of the sensitivity, 
specificity, predictive values and likelihood ratios as statistical performance 
measures is shown and a description of their significance is presented. The chap-
ter concludes with a comparison between the performance of a cardiologist and 
the autonomous auscultation system. 
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6. CONCLUSIONS AND RECOMMENDA-
TIONS 
6.1 The Autonomous Auscultation System 
The autonomous auscultation system developed in this study and used in con-
cert with the PCG prototype device was able to successfully identify CVD in pa-
tients, with a sensitivity of 82% and specificity of 88%. Similarly, the results ob-
tained with the Auscultation Jacket recordings, had sensitivity and specificity of 
ratings of 76.2% and 90.3%, respectively. The primary objective of this project 
was hereby achieved through the accurate and autonomous screening of patients 
for CVD in a clinical environment. 
Through the use of Telemedicine, the success of this research project has far 
reaching implications in terms of providing 21st century healthcare to rural parts 
of Africa. It is envisioned that patient data could not only be collected by the PCG 
device for screening purposes, but also for remote consultation if a positive 
screening result is established. By transmitting patient data to specialists almost 
anywhere in the world, the system can aid in the early identification of life threat-
ening cardiovascular diseases, which is vital to its effective treatment. 
6.2 Data Acquisition 
The heart sounds and ECG signals of male and female participants, which in-
cluded 34 healthy persons and 28 patients with abnormal heart conditions, were 
successfully recorded at Tygerberg Hospital using the PCG device. The total 
number recorded participants amounted to 114 (including those previously re-
corded with the Auscultation Jacket) and were found to be adequate to train and 
validate the ensemble neural network classification system through implementa-
tion of the leave-one-out cross-validation method. The recording procedure, de-
scribed in Appendix C, was accepted by all participants in the project and no 
negative reactions were encountered while performing recordings with the PCG 
device.  
The PCG device was able to record good quality signals for most of the par-
ticipants. However, for some obese participants the electronic stethoscopes did not 
make proper contact in the correct auscultation positions, and resulted in noisy 
recordings. Also, with these participants the device needed to be pressed against 
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the chest in order for the stethoscopes to sufficiently compress the chest fat under 
the skin. This was necessary for the stethoscopes to effectively measure the vibra-
tions caused by the heart. Without this compression, the fat and the skin absorbed 
most of the vibrations making the heart sounds almost immeasurably faint. In 
some cases it would have been desirable to be able to extend the device along its 
length and have its centre part be flexible to better accommodate patients who suf-
fered from obesity. 
The ECG recording quality was excellent in many of the underweight abnor-
mal and normal participants, but was generally poor for women and obese pa-
tients. This was mainly due to the fact that the limb leads of the ECG did not 
reach far enough towards the shoulders and abdomen of the patient, which creat-
ing noisy or faint traces (Lubbe, 2009). A possible solution would be to attach the 
four limb leads to extension cords, allowing them to be placed to the standard po-
sitions (ankles and wrists). The synchronisation of the ECG and heart sounds also 
posed a major challenge in this project. In future designs this can be solved by 
having an ECG sample through a computer’s soundcard or a compact, multichan-
nel USB soundcard built into the device. This will enable the recording software 
on the PC to synchronise all the signals automatically.  
A future study could benefit if a comparison is not only made between the per-
formance of the autonomous auscultation system and a cardiologist (Section 5.3), 
but with an otherwise qualified clinician such as a nurse or general practitioner as 
well. By comparing their auscultation performance to that of the autonomous aus-
cultation system, the value of such a system could further be illustrated. 
For the future success of a commercial automated auscultation system, an open 
EMR standard for storing and retrieving synchronised heart sound and ECG re-
cordings will be essential. This standard will allow for much better collaboration 
between researchers around the world and, more importantly, aid in the availabil-
ity of data, with which to test the performance of current and future systems. 
6.3 Feature Extraction 
Identification of significant features which would indicate the presence of CVD 
in heart sounds remains a subject that requires active research. It lies at the heart 
of the autonomous auscultation system and is critical to its screening ability. 
The EEMD data analysis method proved useful in extracting significant fea-
tures from heart sounds. Investigation of the method showed it has an exceptional 
ability to decompose heart sounds into meaningful components. Spectral analysis 
of these components through the application of auto regressive modelling yielded 
features which resulted in a significant screening improvement over the pathol-
Stellenbosch University http://scholar.sun.ac.za
67 
ogy-based, time domain features. Unfortunately, due to time constraints posed on 
this study the spectral characteristics of the implemented, 12-order, auto regres-
sive models could not be investigated further. But, due to the success of this 
method its future research is certainly warranted. Principal component analysis as 
well as the statistical overlap factor can also prove useful for providing informa-
tion with regards to which auto regressive coefficients separate the various pa-
thologies best. 
Implementation of certain features from the ECG recordings has significant po-
tential to increase the capabilities of the autonomous auscultation system. Exam-
ples of such ECG features that may prove useful are the height of the P-wave rela-
tive to the R-peak and the appearance of an inverted QRS-complex. A negative T-
wave, the presence of arrhythmias and QRS-axis deviation could also be autono-
mously detected to enhance the screening capabilities of the system.  
6.4 Classification  
The ensemble ANN used in the final implementation of this study was able to 
achieve consistent cross-validation results through repeated training and simula-
tion runs. The cross-validation results from Chapter 5 indicate that the classifica-
tion system was able to adequately generalize over the input space. 
The effects of using each cardiac cycle as an input to the classifier, and thereby 
having multiple multi-dimensional data points per participant, have been briefly 
investigated in this study. However, it was found that only in a few cases an im-
provement was obtained, but overall performance was compromised. Computing 
the median over all the cycles of each participant yielded better and more consis-
tent results overall. 
To further assist clinicians in the decision making process, a future version of 
the software could graphically portray the weights of the trained ANN. This could 
be beneficial as it would indicate how the network derives a particular result and 
not just appear to function as a black box. 
The implementation of a single, unitary artificial neural network for classifica-
tion was investigated, but the ensemble ANN repeatedly achieved superior results. 
The ensemble method also leaves much room for future investigation and further 
improvement. Increasing the number of ensemble members could potentially in-
crease performance, although at the cost of computational speed. Different meth-
ods for combining the ensemble decisions also warrant investigation.  
The addition of dynamic weights to the decisions of ensemble members could 
yield a significant improvement in future systems. Making the weights adjustable 
based on the certainty of each member’s output, or whether a problematic output 
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is produced (Section 5.2), will form a critical part of future work along this line. 
6.5 A note on Classification Performance and Hardware 
Through the development of the current autonomous auscultation system, an 
issue of bias in the results was raised. By adjusting neural network parameters and 
choosing features based on classification performance, may have biased the sys-
tem around the current data. Ideally, a separate dataset should have been kept 
which has not been used during the development of the system. This dataset is 
then used to test the system, after completion of its development, to determine its 
unbiased performance. However, due to the limited amount of available data, this 
was not practical in the current study. It is, however, strongly recommended for 
future development and testing of the system. 
Combining the data recorded with the PCG device and the Auscultation Jacket 
into the same training and simulation datasets led to an extremely poor classifica-
tion ability of the system. This phenomenon is attributed to the differences of the 
recording hardware. The fact that the positioning of the stethoscopes in the de-
vices is not exactly similar, as well as the differences in the bell and diaphragm 
shapes and materials of the two devices, is thought to be the largest contributing 
factors.  
The hypothesis that the autonomous auscultation system is sensitive to the 
physical properties of the recording hardware is further strengthened by the fact 
that when the datasets are evaluated separately, good classification performance 
was achieved, as reported in Chapter 5. This observation led to the conclusion that 
the system must be trained specifically for each type of recording hardware. 
6.6 Achievement of the Project Objectives  
In this section the achievement of the project objectives is summarised and the 
degree to which each of the objectives were obtained is discussed with regard to 
its original formulation. 
6.6.1 Original project objectives 
The objective of this research project was to develop software capable of de-
tecting CVD from heart sounds recorded with electronic stethoscopes. In order to 
achieve this objective the following had to be accomplished: 
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4. Record heart sounds and electrocardiogram (ECG) data from patients 
with CVD as well as from healthy participants. 
5. Research and implement suitable signal processing algorithms for the de-
tection of anomalies in the recorded heart sounds which would indicate 
the presence of CVD. 
6. Develop an automated classification scheme that can successfully parti-
tion the healthy participants from those with CVD. 
7. Cross-validate the implemented classification scheme in a clinical study 
to determine its capability to screen future patients. 
8. Investigate the strengths, weaknesses, feasibility and the acceptance of 
the recording hardware by patients and clinicians in a hospital environ-
ment. 
6.6.2 Project achievements 
The first objective involved a clinical study to assess the practical application 
and performance of the developed autonomous auscultation system. The clinical 
study was executed successfully and the recordings of 34 healthy participants and 
28 patients with CVD could be used to validate the system against the gold stan-
dard echocardiograph. Each participant received the echo and was additionally 
examined by a trained cardiologist. 
The purpose of the second objective was to investigate methods that would 
prove useful for identifying anomalies in the heart sounds of cardiac patients in an 
automated way. The EEMD data analysis method’s application to heart sounds 
was investigated to this end. The research indicated that it provided a useful de-
composition which can be used to identify signs of CVD in these sounds. The 
challenge of automating the analysis was solved by the use of correlation which 
could identify the significant components of the EEMD analysis. To characterise 
these components, the use of auto regressive modelling was investigated. The re-
search showed that the combination of these signal processing algorithms success-
fully provided features which indicated the presence or absence of CVD in the 
heart sound recordings. 
The third and fourth objectives were to develop a classification scheme that 
would identify which participants suffered from CVD and to cross-validate the 
classifier to accurately report its usefulness as a diagnostic screening tool. An en-
semble neural network, discussed in Section 4.6, was developed to this end. The 
ensemble neural network was evaluated with the leave-one-out cross-validation 
method and proved to be a reliable screening tool by producing good cross-
validation results in terms of the sensitivity, specificity and predictive values and 
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likelihood ratios. 
The final objective of the project was to evaluate the PCG device in a clinical 
setting. This objective was achieved as part of the clinical study. Successful 
evaluation of the device was accomplished by enquiring and noting the opinions 
and experiences of the participants and clinicians involved in the study. The com-
fort and/or discomforts related to its application and the recording procedure was 
also investigated among the participants. Some of the physical recordings were 
examined by a cardiologist to obtain their impressions regarding the usefulness, 
quality and clinical relevance of the recordings. It was established that the device 
still requires development, specifically on improving the ECG recording quality 
and automatically synchronising it with heart sounds. Despite these minor short-
comings related to the device, all the participants and clinicians involved found it 
to be a practical tool and realised its potential value in basic medical facilities.  
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Participant
ID # Abn/Norm Diagnosis Class 1 Class 2 Class 1 Class 2 Abn/Norm Confidence
3 N Normal 87 12 1 0 N 87.9%
64 N Normal 79 20 1 0 N 79.8%
39 N Normal 66 33 1 0 N 66.7%
51 N Normal 76 23 1 0 N 76.8%
8 N Normal 81 18 1 0 N 81.8%
63 N Normal 80 19 1 0 N 80.8%
37 N Normal 79 20 1 0 N 79.8%
66 N Normal 81 18 1 0 N 81.8%
67 N Normal 84 15 1 0 N 84.8%
62 N Normal 81 18 1 0 N 81.8%
15 N Normal 74 25 1 0 N 74.7%
61 N Normal 87 12 1 0 N 87.9%
68 N Normal 81 18 1 0 N 81.8%
9 N Normal 78 21 1 0 N 78.8%
10 N Normal 82 17 1 0 N 82.8%
57 N Normal 56 43 1 0 N 56.6%
12 N Normal 80 19 1 0 N 80.8%
16 N Normal 74 25 1 0 N 74.7%
69 N Normal 74 25 1 0 N 74.7%
22 N Normal 83 16 1 0 N 83.8%
24 N Normal 82 17 1 0 N 82.8%
25 N Normal 91 8 1 0 N 91.9%
26 N Normal 86 13 1 0 N 86.9%
27 N Normal 86 13 1 0 N 86.9%
30 N Normal 67 32 1 0 N 67.7%
31 N Normal 90 9 1 0 N 90.9%
32 N Normal 87 12 1 0 N 87.9%
33 N Normal 88 11 1 0 N 88.9%
34 N Normal 91 8 1 0 N 91.9%
35 N Normal 71 28 1 0 N 71.7%
38 N Normal 16 83 0 1 A 83.8%
47 N Normal 26 73 0 1 A 73.7%
65 N Normal 9 90 0 1 A 90.9%
28 N Normal 41 58 0 1 A 58.6%
14 A AS,AR,MS,MR 39 60 0 1 A 60.6%
18 A MR,AR 18 81 0 1 A 81.8%
Classification outputEchocardiograph Ensemble decisions
7. APPENDIX A: PARTICIPANT DATA 
 
Table A1: PCG device test output (2009/10). 
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Participant
ID # Abn/Norm Diagnosis Class 1 Class 2 Class 1 Class 2 Abn/Norm Confidence
Classification outputEchocardiograph Ensemble decisions
19 A MR 19 80 0 1 A 80.8%
20 A MS 19 80 0 1 A 80.8%
21 A AR 21 78 0 1 A 78.8%
29 A AS 34 65 0 1 A 65.7%
40 A MS,MR,AR 15 84 0 1 A 84.8%
41 A MR 40 59 0 1 A 59.6%
42 A MR,AR,AS 9 90 0 1 A 90.9%
43 A AR,AS 15 84 0 1 A 84.8%
44 A AS 11 88 0 1 A 88.9%
45 A VSD 16 83 0 1 A 83.8%
46 A AS 40 59 0 1 A 59.6%
48 A PS 19 80 0 1 A 80.8%
49 A AS 19 80 0 1 A 80.8%
50 A VSD 23 76 0 1 A 76.8%
52 A MS 36 63 0 1 A 63.6%
53 A AS 27 72 0 1 A 72.7%
55 A MR 13 86 0 1 A 86.9%
56 A AS 12 87 0 1 A 87.9%
58 A MR 42 57 0 1 A 57.6%
59 A MR,AR,AS 14 85 0 1 A 85.9%
4 A MR 45 54 0 1 A 54.5%
23 A AR 81 18 1 0 N 81.8%
36 A MS 71 28 1 0 N 71.7%
54 A prosthetic MV 61 38 1 0 N 61.6%
17 A MR 91 8 1 0 N 91.9%
60 A MS 57 42 1 0 N 57.6%
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Participant Abn/Norm Diagnosis Class 1 Class 2 Class 1 Class 2 Abn/Norm Confidence
1 N Normal 85 14 1 0 N 85.9%
2 N Normal 57 42 1 0 N 57.6%
3 N Normal 96 3 1 0 N 97.0%
4 N Normal 91 8 1 0 N 91.9%
5 N Normal 94 5 1 0 N 94.9%
6 N Normal 92 7 1 0 N 92.9%
7 N Normal 98 1 1 0 N 99.0%
8 N Normal 94 5 1 0 N 94.9%
9 N Normal 89 10 1 0 N 89.9%
10 N Normal 95 4 1 0 N 96.0%
11 N Normal 94 5 1 0 N 94.9%
12 N Normal 94 5 1 0 N 94.9%
13 N Normal 87 12 1 0 N 87.9%
14 N Normal 93 6 1 0 N 93.9%
15 N Normal 95 4 1 0 N 96.0%
16 N Normal 94 5 1 0 N 94.9%
17 N Normal 93 6 1 0 N 93.9%
18 N Normal 93 6 1 0 N 93.9%
19 N Normal 97 2 1 0 N 98.0%
20 N Normal 90 9 1 0 N 90.9%
21 N Normal 92 7 1 0 N 92.9%
22 N Normal 91 8 1 0 N 91.9%
23 N Normal 96 3 1 0 N 97.0%
24 N Normal 95 4 1 0 N 96.0%
25 N Normal 98 1 1 0 N 99.0%
26 N Normal 60 39 1 0 N 60.6%
27 N Normal 89 10 1 0 N 89.9%
28 N Normal 92 7 1 0 N 92.9%
29 N Normal 19 80 0 1 A 80.8%
30 N Normal 16 83 0 1 A 83.8%
31 N Normal 9 90 0 1 A 90.9%
32 A AS,MS,AR,MR 15 84 0 1 A 84.8%
33 A MS,MR 13 86 0 1 A 86.9%
34 A VSD,AR,PR 8 91 0 1 A 91.9%
35 A AR 11 88 0 1 A 88.9%
36 A AR 27 72 0 1 A 72.7%
37 A AR 21 78 0 1 A 78.8%
38 A AS,AR,MS 45 54 0 1 A 54.5%
39 A MR,PR 23 76 0 1 A 76.8%
40 A AR,MR 23 76 0 1 A 76.8%
41 A MS,MR,AR 8 91 0 1 A 91.9%
42 A AS,AR,MR 5 94 0 1 A 94.9%
43 A MR 8 91 0 1 A 91.9%
44 A MS,MR 17 82 0 1 A 82.8%
45 A MR 21 78 0 1 A 78.8%
46 A AS,MS,AR,MR 18 81 0 1 A 81.8%
47 A AR 19 80 0 1 A 80.8%
48 A MR 73 26 1 0 N 73.7%
49 A VSD 89 10 1 0 N 89.9%
50 A MR 64 35 1 0 N 64.6%
51 A MR,AS,AR 91 8 1 0 N 91.9%
52 A VSD 94 5 1 0 N 94.9%
Echocardiograph Ensemble decisions Classification output
Table A2: Auscultation Jacket test output (2009/10). 
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Member Class 1 (N) Class 2 (A) Class 1 (N) Class 2 (A)
1 0.9677 0.9255 1 0
2 0.0166 0.9974 0 1
3 0.0017 0.9992 0 1
4 0.0130 0.9146 0 1
5 0.0043 0.9931 0 1
6 0.0000 1.0000 0 1
7 0.0005 0.9997 0 1
8 0.0013 0.9920 0 1
9 0.0066 0.9933 0 1
10 0.0000 1.0000 0 1
11 0.4938 0.9987 0 1
12 0.1101 0.9953 0 1
13 0.0032 0.9576 0 1
14 0.0090 0.6011 0 1
15 0.1539 0.9991 0 1
16 0.0008 0.9961 0 1
17 0.0000 1.0000 0 1
18 0.0033 0.9799 0 1
19 0.2143 0.9962 0 1
20 0.0183 0.9744 0 1
21 0.9813 0.9633 1 0
22 0.0036 0.9801 0 1
23 0.0000 1.0000 0 1
24 0.0092 0.9993 0 1
25 0.6178 0.6204 0 1
26 0.0000 1.0000 0 1
27 0.1618 0.9926 0 1
28 0.2251 0.9529 0 1
29 0.0022 0.9889 0 1
30 0.1849 0.9207 0 1
31 0.0000 1.0000 0 1
32 0.0000 0.9994 0 1
33 0.0029 0.9989 0 1
34 0.0107 0.0069 1 0
35 0.0187 0.9879 0 1
36 0.0042 0.9995 0 1
37 0.0000 1.0000 0 1
38 0.9977 0.0437 1 0
39 0.0002 0.9991 0 1
40 0.4813 0.8547 0 1
41 0.0001 0.8682 0 1
42 0.1375 0.9270 0 1
43 0.0000 1.0000 0 1
44 0.0011 0.9988 0 1
45 0.0016 0.8765 0 1
46 0.0052 0.9460 0 1
47 0.3578 0.8737 0 1
48 0.1357 0.5334 0 1
49 0.8260 0.9774 0 1
50 0.0340 0.9690 0 1
51 0.0458 0.9996 0 1
52 0.9986 0.9977 1 0
53 0.9953 0.0085 1 0
54 0.0000 1.0000 0 1
55 0.9793 0.0399 1 0
Neural Net DecisionsEnsemble Neural Net Outputs
Table A3: Auscultation Jacket participant #35. Example output 
of ensemble neural network decisions. 
Stellenbosch University http://scholar.sun.ac.za
75 
 
Member Class 1 (N) Class 2 (A) Class 1 (N) Class 2 (A)
Neural Net DecisionsEnsemble Neural Net Outputs
56 0.4506 0.9652 0 1
57 0.0017 0.9850 0 1
58 0.0009 0.9998 0 1
59 0.0015 0.6203 0 1
60 0.0006 0.9892 0 1
61 0.0007 0.9824 0 1
62 0.0609 0.9662 0 1
63 0.0006 1.0000 0 1
64 0.0001 0.0000 1 0
65 0.1074 0.1705 0 1
66 0.1594 0.9428 0 1
67 0.0102 0.5323 0 1
68 0.4734 0.7501 0 1
69 0.0000 0.9981 0 1
70 0.0000 1.0000 0 1
71 0.0492 0.9947 0 1
72 0.0262 0.9792 0 1
73 0.2570 0.8951 0 1
74 0.1570 0.9650 0 1
75 0.0423 0.9954 0 1
76 0.4506 0.6477 0 1
77 0.0001 0.9995 0 1
78 0.0058 0.9996 0 1
79 0.0101 0.0523 0 1
80 0.0033 0.9996 0 1
81 0.0940 0.9880 0 1
82 0.4449 0.6401 0 1
83 0.9864 0.8065 1 0
84 0.0000 1.0000 0 1
85 0.0451 0.9030 0 1
86 0.0367 0.6772 0 1
87 0.8494 0.0217 1 0
88 0.0000 1.0000 0 1
89 0.0000 1.0000 0 1
90 0.1303 0.4812 0 1
91 0.0000 0.0077 0 1
92 0.0000 0.9999 0 1
93 0.0197 0.8622 0 1
94 0.1063 0.9985 0 1
95 0.1445 0.0017 1 0
96 0.0012 0.9985 0 1
97 0.0560 0.9709 0 1
98 0.0002 1.0000 0 1
99 0.0361 0.9910 0 1
11 88Total Decisions:
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Table A4: Participants recorded with the PCG device at 
Tygerberg Hospital (2008/06 - 2009/06). 
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8. APPENDIX B: CONSENT FORM 
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9. APPENDIX C: RECORDING PROCEDURE 
 
The procedure that was used to record participants’ data at Tygerberg Hospital 
for this study was as follows:  
1. The volunteer is informed about the study, its purpose and the procedure 
for performing recordings. 
2. The participant signs the consent form. 
3. The participant is instructed to lie on his/her back with the headrest of the 
bed inclined at 30°. 
4. Electrolyte gel is placed on the ECG electrodes 
5. The PCG device is placed on the participant’s chest with the stethoscopes 
at the auscultation positions. 
6. The ECG and heart sound recordings are initiated on the PC. 
7. The device is tapped to create intentional artefacts in the signals. 
8. Record for 30 seconds. 
9. Instruct the participant to take a deep breath, exhale and not to inhale for as 
long as possible.  
10. Record for 30 seconds after the participant has again inhaled. 
11. Save the audio recording as a pulse-code modulated wave file and the ECG 
in a text file on the personal computer. 
12. Repeat 3 more times from step 4. 
13. A separate 12-lead ECG is recorded by the clinician. 
14. The participant is examined by the cardiologist with only a stethoscope. 
15. The participant is examined by an echocardiograph. 
 
 
Stellenbosch University http://scholar.sun.ac.za
  
83 
10. APPENDIX D: CARDIOLOGIST FORM 
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11. APPENDIX E: SOUNDCARD ECG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Soundcard ECG printed circuit board layout with 
component overlay. 
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Figure A2: Soundcard ECG circuit diagram. 
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